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7Abstract
The innate immune system is the first line of defence against microbial infections,
thus a detailed understanding of its mechanisms is essential in devising new
therapeutical interventions to combat inflammatory or infectious diseases.
Macrophages are key immune cells in the innate immune system, reacting in
various ways to immunological stimulation, including both conventional and
extracellular vesicle (EV)-mediated protein secretion. These protein secretion
pathways are major components of intercellular communication in the immune
system. Protein secretion can be triggered by the activation of large cytosolic
complexes called inflammasomes; these are assembled when the cell detects
danger associated molecules. Inflammasome activation leads to activation of
proteolytic enzymes and release of pro-inflammatory cytokines and it is an
integral part of many inflammatory diseases.
The secretome of the cell is the pattern of all secreted molecules at a given
time; it can provide important insights about the cell’s status as well as
information about intercellular communication. The secretome can be studied by
mass spectrometry (MS)-based proteomics; this technique provides a system-
level overview of the current state of the cell. While traditional assays like ELISA
or Luminex can quantify selected proteins in low pg/mL levels, they can only
analyse a limited number of proteins. Proteomics offers the same sensitivity but
supplemented with the capability of multiplex quantitative analysis of thousands
of proteins in the same sample.
The  main  goal  of  this  work  was  to  unravel  the  innate  immune response  of
human macrophages activated by microbial stimuli with a focus on protein
secretion using proteomics combined with bioinformatics and functional studies.
Influenza A virus (Study I) and gram-negative bacterial cell wall component
lipopolysaccharide (LPS, Study II) are known to activate canonical NLRP3
inflammasome and non-canonical caspase-4/5 inflammasome, respectively.
Inflammasome activation is followed by protein secretion which was studied in
8detail, with a special emphasis on unconventional protein secretion. In both
studies, mediators of inflammation were released and the EVs carried modulators
of  immune  responses,  evidence  of  the  major  role  of  EVs  as  a  means  of
intercellular communication.
Influenza A viruses (IAVs) are aggressive pathogens causing acute
respiratory diseases and annual epidemics in humans. IAV infection of human
macrophages is associated with robust secretion of proteins via conventional and
unconventional protein release pathways. EVs from infected and non-infected
cells were isolated and characterized using proteomics, bioinformatics, and
functional studies. This led to the identification of 2359 human proteins from
EVs of IAV-infected macrophages compared with 1448 proteins identified from
EVs of control cells. Bioinformatic analysis revealed that many translation-
associated proteins had been secreted in response to IAV infection. Furthermore,
EVs derived from IAV-infected macrophages contained fatty acid-binding
proteins, antiviral cytokines, copper metabolism Murr-1 domain proteins, and
autophagy-related proteins. In addition, secretory autophagy was considered to
play a role in activating EV-mediated protein secretion during IAV infection
Gram-negative bacteria are associated with a wide spectrum of infectious
diseases in humans. The non-canonical caspase-4/5 inflammasome is activated
by gram-negative bacteria-derived LPS and by endogenous oxidized
phospholipids. This inflammasome is associated with endotoxic shock, and it is
believed to play a role in several  inflammatory diseases.  In study II,  label-free
quantitative proteomics was utilised to characterize the global protein secretion
from human macrophages after intracellular LPS recognition, which triggered
non-canonical inflammasome activation. Prior to undergoing proteomics, the
total secretome was separated into two fractions: EV-enriched fraction and rest-
secretome (RS) fraction. MS-based proteomics lead to the identification of 1048
proteins from the EV fraction and 1223 proteins from the RS fraction, 640 of
these proteins were present in both fractions, suggesting that the non-canonical
inflammasome activates multiple, partly overlapping, protein secretion
pathways. The RS fraction was highly enriched with inflammation-associated
proteins upon intracellular LPS recognition. Several ribosomal proteins were
highly abundant in the EV fraction after infection, evidence that secretion of
translational machinery is an important part of the host response against
infections with gram-negative bacteria. Intracellular recognition of LPS resulted
in  the  secretion  of  two  metalloproteinases  known  to  be  associated  with  the
9secretion of TNF, a key inflammatory cytokine and M-CSF, an important growth
factor for myeloid cells. These were probably released through membrane
shedding of these cytokines. Caspase-4/5 inflammasome activation also resulted
in the secretion of danger associated molecules in the enriched EV fraction which
activated TLR4 signalling; this points towards a pro-inflammatory feed-back
loop that may be contributing to aberrant inflammation during non-canonical
inflammasome activation as encountered in endotoxic shock.
Proteomics and secretome analysis can provide in-depth information on the
molecular mechanisms involved in innate immune response. The exploitation of
these methods in study I and II provided a deeper understanding of the general
innate immune response to microbial stimuli, shedding light on the role of EVs
in the immune response, and identifying several potentially important new
players in viral infection. The results highlight the important role of autophagy
in protein secretion and reveal novel therapeutic targets both in viral infections
and caspase-4/5 dependent disease states such as endotoxic shock.
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I Introduction
1 Innate immunity
Immunity can be divided into two parts: the immediate, inborn or innate
immunity, and the slower, adaptive or learned immunity which generates the
immunological memory. Innate immunity is an evolutionarily conserved system,
which serves as the first line of protection against invading microbial pathogens
(Medzhitov, 2007). It includes natural barriers on self-not-self interfaces like skin
or the mucosal epithelia in the respiratory and gastrointestinal tracts, chemical
defence such as the low pH of the stomach, humoral defence i.e. antimicrobial
peptides present in the mucus of the lungs. Once a pathogen breaches these
barriers, it encounters the complement system consisting of serum-circulating
proteins as well as membrane-bound proteins like receptors and regulators. The
detection of microorganisms by fluid-phase complement components leads to the
activation of the complement cascade which is intended to eliminate the
microbial  target  (Kolev  et  al.,  2014).  The  complement  system  can  also  mark
invaders for phagocytosis by binding peptides or antibodies on the surface of the
microorganism, a process called opsonisation.
Here the focus is placed on the activities of inflammatory phagocytes; these
are the cells which clear out cell debris or pathogens as well as activating the
adaptive immune system via the major histocompatibility complex (MHC) class
II system. The MHC complexes are cell surface protein complexes which present
peptides to the adaptive immune cells. MHC class I molecules are found on the
cell surface of all nucleated cells and therefore not in red blood cells; their
function is to display peptide fragments of non-self-proteins which originate from
the cytosol. MHC class II molecules are found only on antigen-presenting (APC)
cells, they present antigens of non-self-proteins originating from extracellular
16
proteins digested after phagocytosis. The components of the innate immune
system are summarised in Figure 1.
Figure 1: Components of the innate immune system. The innate immune
system consists of anatomical barriers such as skin epithelia, biological defence
such as the immunopeptidome, and chemical defence such as extreme pH values.
If the barriers are breached by an invading pathogen, the invader is likely to be
detected by the complement system or the cells of the innate immune system
leading to the invader’s destruction. Another way to kill a pathogen is to mark it
with peptides or antibodies in a process called opsonisation, resulting in the
recruitment of phagocytes. The phagocyte engulfs the pathogen and digests it,
prior to presenting critical antigens to the adaptive immune cells. Activated
phagocytes also detect danger-associated molecular patterns (DAMPs) and
pathogen-associated molecular patterns (PAMPs) themselves, initiate translation
of pro-inflammatory proteins, and induce inflammation by releasing cytokines,
interferons, alarmins and other messengers.
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1.1 Cells of the innate immune system
Most immune cells originate from the bone marrow, which houses the
hematopoietic stem cells (Figure 2). These stem cells divide into two different
stem cell  types:  the  common lymphoid  progenitor  cell  gives  rise  to  B cells,  T
cells, natural killer cells (Nk cells), innate lymphoid cells (ILCs) as well as to
dendritic cells (DCs). The common myeloid progenitor cell produces the myeloid
lineage, consisting of granulocytes neutrophils, basophils and eosinophils as well
as mast cells, monocytes and thus macrophages, platelets and erythrocytes, as
well  as  DCs.  Most,  but  not  all,  DCs  originate  from  the  myeloid  lineage.
Neutrophils, macrophages and DCs are inflammatory phagocytes; macrophages
and DCs are capable of activating the adaptive immune response by presenting
phagocytosed antigens via the MHC class II peptides to T cells.
Figure 2: The cells of the immune system: Most immune cells originate from
pluripotent hematopoietic stem cells in the bone marrow (blue background),
which differentiate either into the common myeloid progenitor or the common
lymphoid progenitor and hence give rise to the myeloid or lymphoid lineages.
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The myeloid lineage consists of innate immune cells, the myeloid progenitor
differentiates into the granulocyte/macrophage progenitor from which they
develop into monocytes or granulocytes, or via another progenitor step to
produce erythroblasts or megakaryocytes in the bone marrow, which in turn give
rise to erythrocytes and platelets, respectively. After stimulation, monocytes in
the blood (green background) can extravasate into tissue (orange background)
and differentiate into macrophages. DCs are mainly myeloid cells but can also
originate from lymphoid progenitors. They extravasate into the tissue and mature
upon activation after exposure to potential pathogens. Mast cells also mature in
the tissue. The lymphoid cells are Nk cells, B cells, T cells and ILCs. B and T
cells are the only lymphocytes with antigen receptors; when encountering
antigens, they become activated into plasma cells and effector T-cells,
respectively. Adapted from (Murphy and Weaver, 2016).
1.1.1 Macrophages
Macrophages, as DCs, play an important role in tissue homeostasis and defence.
They eliminate the pathogen by phagocytosis, clear out the debris from dead cells
and initiate tissue repair as well as alerting adaptive immune cells about
pathogens by presenting peptide residues via their MHC class II complex.
Macrophages also initiate and control inflammation by releasing cytokines.
Most macrophage populations are tissue resident, self-renewing and were
seeded into the tissues before birth (Sieweke and Allen, 2013). These resident
macrophages are derived from the yolk sac and fetal liver; they are heterogeneous
and versatile cells found in virtually all tissues where they can amount to 10–
15% of the total cell number and even higher numbers during inflammation
(Italiani and Boraschi, 2014, Hashimoto et al., 2013). Examples for these tissue-
resident macrophages are reviewed in (Gordon et al., 2014) represented in table
1.
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Table 1: Examples of tissue-resident macrophage populations in humans.
Tissue-resident macrophages Tissue
Osteoclasts Bone
Alveolar macrophages Pulmonary alveoli of lungs
Microglia Brain
Histiocytes Connective tissue
Kupffer cells Liver
Langerhans cells Skin
Sinus Histiocytes Lymph nodes
Hofbauer cells Placenta
Intraglomerular mesangial cells Kidney
Epithelioid cells Granulomas
Red pulp macrophages (Sinusoidal lining cells) Red pulp of spleen
The tissue-resident macrophages interact extensively with their environment
since they perform many tasks in addition to the homeostatic clearance of dead
or dying cells. For example, they have a role as trophic cells with involvement in
branching morphogenesis, neuronal patterning, angiogenesis, bone
morphogenesis and the generation of adipose tissue (Pollard, 2009). As part of
their interaction with the surrounding tissue, macrophages release and capture
secretory products such as exosomes, microvesicles, enzymes such as lysozyme,
proteinases, pro- and anti-inflammatory cytokines, chemokines and growth
factors, and metabolites (Gordon et al., 2014).
Some macrophages derive from monocytes in the myeloid lineage. These
monocytes enter the bloodstream and extravasate into the tissue; once there, they
differentiate into macrophages or DCs. The differentiation from monocytes into
macrophages does not always adhere to the same pathway, as macrophages can
exist in two different polarization types (Italiani and Boraschi, 2014). Essentially,
macrophages are able to modify their metabolic functions from a setting which
promotes healing and growth to a pro-inflammatory setting which activates their
killing and inhibitory capacities. They achieve this switch by diverting their
arginine metabolism from the cell proliferation promoting ornithine production
to cell division inhibiting nitrogen monoxide (NO) (Mills et al., 2000). The
healing and proliferation cell type can be considered as the default setting in
tissue-resident macrophages (Murray and Wynn, 2011) while the pro-
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inflammatory state represents macrophages differentiating from extravasated
monocytes.  The  two cell  types  represent  extremes  of  a  continuum which  have
distinct cytokine and chemokine production profiles (Mantovani et al., 2004).
The diverse polarisation states are induced by different cytokines and growth
factors; in laboratory settings this can be achieved by differentiating monocytes
by exposing them to colony stimulating growth factors macrophage colony-
stimulating  factor  (M-CSF)  if  one  wishes  the  healing  polarisation  and  to
granulocyte-macrophage colony-stimulating factor (GM-CSF) to create the pro-
inflammatory state.
1.2 Pattern recognition receptors
Immunity depends on the discrimination between self and non-self. Pattern
recognition receptors (PRRs) fulfil this function by binding ligands which
originate from microbial invaders called microbial-derived PAMPs. They can
also bind certain molecules resulting from “self” such as DAMPs e.g.
extracellular adenosine triphosphate (ATP) which is released from cells after the
loss of membrane integrity.
PRRs are divided into families based on their sequence homology,
intracellular localisation, as well as their downstream signalling (reviewed in
(Odendall and Kagan, 2017)). These receptors can be membrane-bound like the
toll-like receptor (TLR) family, and the C-type lectin receptor (CLR) family
which sense extracellular danger, or located in the cytoplasm like the nucleotide-
binding leucine rich repeat containing protein receptor (NLR) family, retinoic
acid-inducible gene I (RIG-I)-like receptors (RLRs) as well as absent in
melanoma 2 (AIM2)-like receptors (ALRs).
TLRs are transmembrane receptors, which upon stimulation, trigger a
signalling cascade which starts with the association of myeloid differentiation
primary-response protein 88 (MyD88), and ends with the translocation of
transcription factor nuclear factor ?-light-chain-enhancer of activated B cells
(NF-?B) to the nucleus where it induces the transcription of genes responsible
for both the innate and adaptive immune response (Akira and Takeda, 2004). The
members of some important TLR families, their ligands, and cell types
expressing receptors are summarised in table 2.
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Table 2: TLR receptors. TLRs are able to sense and respond to an array of
microbial components. Plasmacytoid DCs (pDCs) are circulating DCs, RNA
sensors can recognize double-stranded (dsRNA) or single-stranded RNA
(ssRNA). Table adapted from (Murphy and Weaver, 2016).
TLR Senses Expressed by
TLR-1/TLR-2
Heterodimer
Lipomannans (mycobacteria),
Lipoproteins, Lipoteichoic acids
(gram-positive bacteria), ?-glucans
(bacterial and fungal cell walls),
Zymosan (fungi)
Monocytes, DCs, mast
cells, eosinophils, basophilsTLR-2/TLR-6
Heterodimer
TLR-3 dsRNA (Viruses), Poly(I:C) Macrophages, DCs,intestinal epithelium
TLR-4
Lipopolysaccharides (gram-negative
bacteria), Lipoteichoic acids (gram-
positive bacteria)
Macrophages, DCs, mast
cells, eosinophils
TLR-5 Bacterial flagella Intestinal epithelium,macrophages, DCs
TLR-7 ssRNA (viruses) pDCs, macrophages,eosinophils, B cells
TLR-8 ssRNA (viruses) phagocytizedbacterial RNA Macrophages, neutrophils
TLR-9 DNA with unmethylated CpG(bacteria and herpes viruses)
pDCs, eosinophils, B cells,
basophils
TLR-10 Unknown pDCs, eosinophils, B cells,basophils
CLRs are a large family of more than 16 PRRs that recognize PAMPs present
in almost all infectious pathogens such as mannose from viruses, fungi, and
mycobacteria, fucose originating from bacteria and helminth parasites, as well as
glucans from mycobacteria and fungi (Geijtenbeek and Gringhuis, 2009). CLRs
exist both as soluble and transmembrane receptors and, depending on their
ligand, the transmembrane receptors can be endocytic or signalling receptors.
The signalling receptors can either directly activate NF-?B or act indirectly by
stimulating TLRs. Transmembrane CLRs can be divided into two groups, group
I CLRs belong to the mannose receptor family and group II CLRs belong to the
asialoglycoprotein receptor family and include the DC-associated C-type lectin
1 (Dectin 1), which is important for sensing the fungal cell wall component ?-
glucan (Geijtenbeek and Gringhuis, 2009).
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NLRs  are  a  family  of  22  cytosolic  PRRs,  NOD1,  NOD2,  CIITA,  NAIP,
NLRC3-5, NLRP1-14, and NLRX1, which are primarily involved in bacterial
recognition  (Franchi  et  al.,  2009).  However,  some  members  such  as  NACHT,
LRR and PYD domains-containing protein 3 (NLRP3) recognise many different
DAMPs and PAMPs (Franchi et al., 2009).
RLRs are a group of three cytosolic RNA helicases known to detect dsRNA
and ssRNA named RIG-I and Melanoma differentiation-associated protein 5
(MDA5)  (Takeuchi  and  Akira,  2008)  as  well  as  Laboratory  of  Genetics  and
Physiology 2 (LGP2) (Satoh et al., 2010, Yoneyama et al., 2005).
ALRs are cytosolic receptors sensing viral DNA. So far, only two members
have been described, absent in melanoma 2  (AIM2) (Hornung et al., 2009) and
IFN?-inducible protein 16 (IFI16) (Unterholzner et al., 2010).
Together, these PRRs recognize diverse ligands from all groups of pathogens,
and their activation induces the release of cytokines, chemokines, and co-
stimulating factors.
1.3 Inflammasomes
Inflammasomes are cytosolic protein complexes which were first described by
Martinon and co-workers in 2002 (Martinon et al., 2002) who reported the
discovery of a caspase-activating complex that was assembled in the cytoplasm
to mediate the proteolytic activation of pro-inflammatory cytokine interleukin
(IL)-1?. They characterized the basic architecture of the human NLRP1
inflammasome as consisting of caspase-1, caspase-5, Apoptosis-associated
speck-like protein (Pycard/ASC), and NALP1. The structure of inflammasomes
is depicted with the example of the NLRP3 inflammasome in figure 3.
In general, inflammasomes comprise a cytosolic PRR which often belong to
the NLR family (Bauernfeind and Hornung, 2013). Several receptors have been
observed to form an inflammasome: NLRP1, NLRP3, NLRC4, AIM2 and pyrin.
Furthermore, IFI16, RIG-I, NLRP6, NLRP7 and NLRP12 are believed to be able
to form inflammasomes.
The assembly of these protein complexes is a stepwise process: the leucocyte-
rich repeat (LRR) domains of the cytosolic PRR is triggered to aggregate after
the recognition event. This aggregation induces the pyrin domain of the PRR to
interact with pyrin domains of the ASC adapter proteins,  which contain an N-
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terminal Pyrin domain and a C-terminal Caspase activation and recruitment
domain (CARD) domain. This structure allows the protein to oligomerise. The
C-terminal CARD domain then interacts with CARD domains of the zymogen
capsase-1, which then oligomerise into filamentous structures which undergo
activation by auto-cleavage and start the proteolytic processing of the inactive
pro-forms of inflammatory cytokines IL-1? and IL-18 resulting in their activation
and subsequent secretion.
1.3.1 The NLRP3 inflammasome
The NLRP3 inflammasome is the best studied of the inflammasomes and its
activation has been linked to a growing number of chronic inflammatory
diseases.
For successful inflammasome activation, the cell has to upregulate the
transcription of inflammasome components as well as the cytokine pro-forms,
especially NLRP3 and IL-1?. In contrast, IL-18 is more constitutively expressed
and thus might not require increased transcription. In order to upregulate the
production of these proteins, the inflammasome must receive a NF-?B–activating
stimulus as the priming signal; this is usually transmitted via membrane-bound
TLRs  or  CLRs.  These  priming  signals  can  be  microbial  PAMPs,  or  in  sterile
inflammation - DAMPs, as reviewed in (Patel et al., 2017). Priming also induces
NLRP3 deubiquitination and linear ubiquitination and phosphorylation of ASC.
After priming, canonical NLRP3 inflammasome activation requires a second
signal to activate NLRP3 and trigger the assembly of the NLRP3 inflammasome.
NLRP3  does  not  directly  recognise  DAMPs  or  PAMPs,  instead,  it  can  utilize
molecular mechanisms such as relocalization of NLRP3 to the mitochondria,
recognition of markers of mitochondrial disintegration (reactive oxygen species
ROS, mitochondrial DNA, mitochondrial membrane-derived cardiolipins),
potassium efflux through ion channels, and cathepsin release following
destabilization of lysosomal membranes to transduce signal 2.
Upon receiving signal two, NLRP3 nucleates ASC to form filaments through
Pyrin-domain-pyrin-domain interactions. Pro-caspase-1 filaments are
subsequently formed through CARD-CARD interactions, allowing auto-
proteolytic activation of pro-caspase-1 (Guo et al., 2015, Jo et al., 2016). The
activation of the NLRP3 inflammasome assembly is depicted in figure 3.
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It is crucial to keep in mind that many of the studies on inflammasome
activation have been conducted in mice and in mouse cells, which are known to
react differently from human cells in some aspects of this process. For example,
human monocytes and macrophages do not require necessarily a second signal to
activate the NLRP3 inflammasome (Wang et al., 2013).
Figure 3: Activation of the canonical NLRP3 inflammasome. In order to
activate the NLRP3 inflammasome, the cell must receive a first, priming signal
to induce NF-?B-mediated translation of pro-IL-1? and NLRP3. In the next step,
the NLRP3 protein recognises signs of mitochondrial or lysosomal damage or
alternatively a lack of potassium ions, all of which activate the assembly of the
NLRP3 inflammasome.
NLRP3 has been shown to be activated by many very different stimuli, there
are several models depicting how these different activators function: activators
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induce the release of ROS (Tschopp and Schroder, 2010), induce lysosomal
damage (Hornung and Latz, 2010), or lead to cytosolic K+ efflux (Petrilli et al.,
2007). In addition, a role for mitochondrial damage has been proposed, both via
mitochondrial ROS (Zhou et al., 2011) and mitochondrial DNA (Nakahira et al.,
2011). A list of NLRP3 activators is shown in table 3.
Table 3: NLRP3 inflammasome activators
Stimuli Reference
PAMPs
Microbial cell wall
components
MDP (Martinon et al., 2004)
?-glucan (Kumar et al., 2009,
Kankkunen et al., 2010)
Microbial nucleotides DNA (Muruve et al., 2008)
RNA (Kanneganti et al., 2006)
Microbial pore-
forming toxins
Hemolysins (Muñoz-Planillo et al., 2009)
Nigericin (Mariathasan et al., 2006)
Streptolysin (Harder et al., 2009)
Valinomycin (Gurcel et al., 2006)
Viral proteins M2 (IAV) (Ichinohe et al., 2010)
Viroporins (EMCV,
HRSV, poliovirus,
enterovirus, rhinovirus)
(Ito et al., 2012, Triantafilou
et al., 2013)
Pathogens Staphylococcus aureus (Mariathasan et al., 2006)
Listeria monocytogenes (Mariathasan et al., 2006)
Group B Streptococci (Costa et al., 2012)
Neisseria gonorrhoeae (Duncan et al., 2009)
DAMPs
Ion channel activator ATP (Perregaux et al., 1996)
K+ efflux (Petrilli et al., 2007)
Mitochondrial stress
signals
Mitochondrial DNA (Nakahira et al., 2011)
ROS (Zhou et al., 2011)
Inflammation
mediators
SAA acute phase protein (Niemi et al., 2011)
Complement protein C3a (Asgari et al., 2013)
Adjuvants Alum (Li et al., 2008, Hornung et
al., 2008)
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Stimuli Reference
Aggregates and
crystals
Silica crystals (Martinon et al., 2006)
Cholesterol (Rajamäki et al., 2010,
Duewell et al., 2010)
MSU (Martinon et al., 2006)
Environmental irritants
Particles Asbestos (Dostert et al., 2008)
Nanoparticles (Palomäki et al., 2011)
Dust, emission particles (Hirota et al., 2012)
UV treatment (Feldmeyer et al., 2007)
Acidic pH (Rajamäki et al., 2013)
Diet
Dietary saturated fatty
acids
(Wen et al., 2011)
Other inflammasomes
Caspase-4/5 activation (Yang et al., 2015)
EMCV = Encephalomyocarditis virus, HRSV = Human respiratory syncytial
virus, SAA = Serum amyloid A, M2 = Matrix-2 protein
 1.3.2 The non-canonical inflammasome
The non-canonical inflammasome was first described by Kayagaki and
colleagues (Kayagaki et al., 2011). Until the appearance of their landmark paper
in 2011, the consensus was that two proteases, caspase-1 and caspase-11, the
mouse orthologue of human caspase-4, have non-redundant roles in similar
signalling pathways. This belief stemmed from earlier studies which showed that
both caspase-1 and caspase-11 knock-out mice were resistant to lethal doses of
glycoprotein present on the cell wall of gram-negative bacteria, called
lipopolysaccharide (LPS) (Li et al., 1995). Kayagaki and colleagues revealed that
these above studies had actually been conducted in mice with a caspase-
1/caspase-11 double knock-out background. In response, they engineered mice
with an artificial chromosome to express caspase-11, and the resistance of the
mice against intracellular LPS disappeared (Kayagaki et al., 2011). This
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demonstrated that LPS recognition and subsequent inflammation was dependent
on mouse caspase-11.
Most inflammasomes activate caspase-1 processing by binding of a DAMP
or PAMP to an upstream PRR; however, caspase-11 is activated by direct binding
to LPS which is a novel form of caspase activation. This contrast in the activation
mechanism is referred to by this inflammasome non-canonical.
Caspase-4 is able to proteolytically process caspase-1 as well as pro-IL-1?,
though with significantly lower efficiency than caspase-1 auto-proteolysis and
pro-IL-1? processing. Pro-caspase-4 directly binds LPS which consequently
activates its oligomerisation and auto-proteolytic activation. The active caspase-
4 cleaves a cytoplasmic protein called gasdermin D (Kayagaki et al., 2015). The
truncated gasdermin D self-associates and forms pores in plasma membrane (Liu
et al., 2016). This results in a form of inflammatory cell death called pyroptosis
as well as the release of two alarmins, IL-1? and HMGB1 (Crowley et al., 2017).
Furthermore, the non-canonical inflammasome is able to activate the NLRP3
inflammasome (Yang et al., 2015) (Figure 4).
Human caspase-4 and caspase-5 share 78% nucleotide sequence identity, they
both directly bind LPS, activate the non-canonical inflammasome, and induce
pyroptosis. Additionally, they both can be functionally interchanged with
caspase-11 in murine models (Man and Kanneganti, 2016, Crowley et al., 2017,
Kayagaki et al., 2013). The caspase-4/5 inflammasome can be activated by
intracellular LPS, cellular stress due to an accumulation of unfolded or misfolded
proteins in the lumen of the endoplasmic reticulum (ER) called ER stress, or
endogenous oxidized phospholipids (Zanoni et al., 2016).
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Figure 4: The non-canonical caspase-4/5 inflammasome. Intracellular LPS,
ER stress, or endogenous oxidized phospholipids can activate the caspase-4/5
inflammasome, which cleaves gasdermin D. The N-terminal truncated forms
oligomerise and create pores in the cell membrane, inducing pyroptotic cell
death. The non-canonical inflammasome activation in turn also activates the
NLRP3 inflammasome.
1.4 Protein secretion as a mechanism of the innate immune response
Many, if not all, cells secrete proteins into their surrounding extracellular fluid.
These secreted proteins can be regulatory molecules such as hormones and
neurotransmitters, enzymes, antibodies, or structural proteins such as collagens.
Protein secretion is one way to transfer materials and messages between cells.
The protein release can be mediated via classical ER-Golgi mechanisms, as well
as through unconventional, vesicle-mediated protein release.
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For decades, it was believed that eukaryotic cells secrete proteins only via the
classical secretory pathway, where they are co-translationally translocated from
ribosomes into the rough ER lumen. Subsequently, they are glycosylated, folded,
and packed into vesicles coated by COPII proteins and translocated to the Golgi-
apparatus in a process called anterograde transport. From the Golgi, the
intracellular vesicles fuse with the plasma membrane and release their cargo into
the extracellular space. If they are to use this pathway, the protein must carry a
signal peptide which destines it for secretion. This process is very important,
Randy W. Schekman, James E. Rothman, and Thomas C. Südhof, were awarded
the Nobel Prize in Physiology or Medicine "for their discoveries of machinery
regulating vesicle traffic, a major transport system in our cells" in 2013 (Ferro-
Novick and Brose, 2013).
1.4.1 Unconventional Protein Secretion
Many of the proteins which are secreted do not possess a signal peptide. These
proteins exit the cells via several distinct mechanisms: 1) pore-mediated
translocation across the plasma membrane; 2) ATP-Binding Cassette (ABC)
transporter-based secretion; or 3) autophagosome/endosome-based secretion
inside membrane-enclosed entities collectively called extracellular vesicles
(EVs) (György et al., 2011, Rabouille, 2017).
The formation of plasma membrane pores allows cytoplasmic cargos known
as cytoplasmic leaderless proteins to translocate across the plasma membrane.
Pore formation can be either self-sustained or driven by inflammation and is a
key mechanism in the release of leaderless proteins from the cytoplasm to the
extracellular space (Rabouille, 2017).
ABC transporters are a highly conserved transport system superfamily. They
consist of multiple subunits, always featuring at least one transmembrane protein
and membrane-associated ATPase. The transporter is opened utilizing the energy
from ATP binding  and  hydrolysis.  These  transporters  can  take  up  a  variety  of
nutrients, biosynthetic precursors, trace metals, or vitamins, and export lipids,
sterols, drugs, and metabolites. Some of these exporters have been associated
with pathological conditions including tumour resistance and cystic fibrosis, and
they play a role in adaptive immunity, as the clearance of infected cells by
cytotoxic  T-lymphocytes  relies  on  the  presentation  of  antigens  on  MHC  I
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molecules on the cell surface. This antigen presentation critically depends on the
translocation of proteasomal degradation products from the cytosol to the lumen
of the ER which is facilitated by ABC transporters (Hinz and Tampé, 2012).
EVs represent an important mode of intercellular communication and
transport proteins, lipids, and RNAs. There are different types of EVs; the largest
are  apoptotic  bodies,  which  originate  from  the  apoptotic  blebs  formed  during
programmed cell death. Microvesicles (MVs) bud directly from the plasma
membrane through a mechanism called shedding. Exosomes are formed when
intraluminal vesicles (ILVs) fuse with early endosomes and multivesicular bodies
(MVBs), and are released by fusion of MVBs with the plasma membrane (Figure
5). A third mechanism has been proposed, where MVBs fuse with secretory
autophagosomes to generate amphisomes which subsequently release the
exosomes into the extracellular space by fusing with the plasma membrane in a
process called secretory autophagy. The biogenesis of membrane vesicles
distinguishes exosomes from MVs and apoptotic bodies. (György et al., 2011).
They also differ in size, with exosomes being the smallest i.e. 50-150 nm in
diameter, MVs around 100-2000 nm and apoptotic bodies 1000-5000 nm.  These
classifications are approximations, as due to the overlapping sizes, the vesicles
are difficult to separate into pure populations. Investigators use not only different
markers for the EVs they study, also the nomenclature varies extensively, and
careful considerations have to be made if a specific EV subset is to be analysed
as studies might represent mixed EV populations (Colombo et al., 2014).
Methods of EV isolations vary; ultracentrifugation is the most widely used
method, floating in sucrose is used to separate putative subsets of EVs, and
recently, affinity purification methods became commercially available. To solve
the issue of varying markers and nomenclatures for EV subgroups, efforts are
underway to standardize protocols so that results from different laboratories will
be more comparable (Witwer et al., 2013).
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The mechanisms underlying the different secretory pathways are not well
understood, but they require the cytoskeleton (actin and microtubules), associated
molecular motors (kinesins and myosins), molecular switches (small GTPases),
and the fusion machinery (SNAREs and tethering factors) (Raposo and
Stoorvogel, 2013).
Figure 5. Pathways of unconventional protein secretion. Microvesicles can
bud directly from the membrane, whereas exosomes originate from early
endosomes fusing with MVBs. Figure adapted from (Raposo and Stoorvogel,
2013)
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1.4.2 Inflammasome activation triggers unconventional protein secretion
One major initiator of unconventional protein secretion is NLRP3 inflammasome
activation, more specifically caspase-1 activation, which has been linked to EV-
mediated protein secretion for almost a decade (Keller et al., 2008).
Known  NLRP3  activators  such  as  MSU  (Valimaki  et  al.,  2013),  ATP
(Valimaki et al., 2016, Qu et al., 2009), nigericin (Zhang et al., 2016) and ?-
glucan (Ohman et al., 2014, Cypryk et al., 2014) all have been demonstrated to
activate EV secretion.
NLRP3 activation not only triggers the unconventional secretion of IL-1? and
IL-18, other cytokines and growth factors are increasingly secreted as well,
including the pro-inflammatory alarmins IL-1? (Groß et al., 2012) and high-
mobility group protein B1 (HMGB1) (Lamkanfi et al., 2010), fibroblast growth
factors (Nickel, 2011), high-mobility group protein B1 (HMGB1), as well as
microRNAs. The latter were shown to be unidirectionally transferred from APCs
to T-cells by exosomes during immune synapsis (Mittelbrunn et al., 2011). The
unconventional secretion pathways exploited by these proteins are not fully
understood; as an example, it has been proposed that IL-1? can leave the cell
using several overlapping pathways. These pathways were proposed to include
trapping of cytosolic IL-1? by secretory lysosomes accumulating IL-1? via
undefined protein transporters; trapping of cytosolic IL-1? by plasma membrane
blebs formed by evaginations of the surface membrane, or by invaginations of
recycling endosomes, or by formation of the initial autophagic isolation
membrane and release of these plasma-enclosed entities. Furthermore, the direct
release of cytosolic IL-1? is possible upon loss of membrane integrity by
pyroptosis or necroptosis (Dubyak, 2012).
1.4.3 EVs and their role in intercellular communication
Evidence for a role of EVs in intercellular communication is strong: firstly, EVs
are taken up efficiently by immune cells. This uptake can be visualised by
fluorescent lipid membrane dyes to stain EV membranes or using membrane
permeable chemical compounds which become confined to the cytosolic lumen
and are cleaved by intracellular esterases into a fluorescent form. These dyes can
be used to visualise internalisation by flow cytometry and confocal microscopy.
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A growing amount of studies use these methods to confirm EV uptake in various
cells as reviewed in (Mulcahy et al., 2014).
Furthermore, EVs have been shown to transfer functional mRNA, miRNA,
and siRNA to receiving cells which induces production of functional proteins or
in  the  case  of  siRNAs  knocks  down  the  synthesis  of  an  endogenous  protein
(Valadi et al., 2007) (Alvarez-Erviti et al., 2011). Also EVs laden with luciferin
substrate resulted in production of bioluminescence in luciferase expressing cells,
further demonstrating the successful delivery of EV cargo (Montecalvo et al.,
2012).
To establish the role of EVs especially in antigen presentation, EVs have been
shown to induce immunological responses. For example, DC derived antigen- or
peptide-bearing exosomes have been shown to induced antigen-specific naïve
CD4+ T cell activation in vivo when injected into mice (Thery et al., 2002). In
another study, EVs were shown to be internalized by immature bone-marrow
derived DCs and sorted into the endocytic compartment to be processed; and EV-
derived peptides were loaded on MHC-II molecules for presentation to CD4(+)
T cells (Morelli et al., 2004). It was also reported that DC-derived EVs are able
to induce activation of CD8+ T cell clones, EVs from monocyte-derived DCs
were loaded with immunogenic viral peptides and added to autologous peripheral
CD8(+) T cells, which lead to the production of IFN? in a dose-dependent
manner.  These  EVs  also  induced  TNF  production  (Admyre  et  al.,  2006).  The
effects of EVs as immune-modulators in vitro and in vivo are reviewed
extensively in (Thery et al., 2009).
In viral infections EVs play a role as well, a recent study demonstrated that
EVs enriched from supernatants of human immunodeficiency virus type-1 (HIV-
1) infected macrophages induced HIV-1 replication in uninfected cells. The virus
therefore uses the cells EV exchange system to complete its life cycle, and EVs
thereby facilitated the viral spread of the virus (Kadiu et al., 2012).
The mechanism responsible for EV internalization into cells is still not fully
understood, various mechanisms have been proposed, including clathrin-
mediated endocytosis, phagocytosis, a regulated form of unspecific uptake of
extracellular material called macropinocytosis, and plasma or endosomal
membrane fusion (Mulcahy et al., 2014).
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1.5 Regulators of inflammation: cytokines, chemokines, and growth
factors
In order to be able to react to danger, immune cells need to be able to
communicate not only with other immune cells but also with non-immune cells,
and many of these intercellular communication messages are in the form of
secreted cytokines, chemokines, and growth factors. These messenger molecules
can assume many roles, such as activation and inhibition of cell functions,
regulation of differentiation, as well as migration and induction of repairs (Striz
et al., 2014). They need to be able to fulfil far-reaching roles in regulating cell
metabolism and organ function throughout the body. However, their secretion
pathways  seem  dependent  on  cell  type  and  cell  state,  and  thus  are  not  fully
understood (Stow and Murray, 2013, Arango Duque and Descoteaux, 2014).
1.5.1. The interleukin-1 family
The Interleukin-1 (IL-1) family (reviewed in (Garlanda et al., 2013)) consists of
seven agonistic ligands (IL-1?, IL-1?, IL-18, IL-33, IL-36?, IL-36?, and IL-36?),
three receptor antagonists (IL-1Ra, IL-36Ra, and IL-38), and an anti-
inflammatory cytokine (IL-37). The members of this family are involved in the
pathogenesis of autoinflammatory, autoimmune, infectious, and degenerative
diseases, and therefore they are important therapeutic targets. Most of these
cytokines are pro-inflammatory, and furthermore they are known to interact with
naïve T cells and therefore are inducers of adaptive immunity (Vigne et al., 2012,
Chung et  al.,  2009).  Interestingly,  none of the IL-1 family ligands has a signal
peptide sequence to allow them to be secreted by conventional mechanisms and
thus are secreted by unconventional mechanisms (Monteleone et al., 2015). There
are known to be eleven IL-1 receptors (IL-1Rs).
Even though IL-1? and IL-1? are both pro-inflammatory and bind to the same
receptor, IL-1R1, nevertheless, their biology is quite different; IL-1? is produced
in activated macrophages, neutrophils, epithelial cells, and endothelial cells. It is
released upon necrotic (Cohen et al., 2010) and pyroptotic (Kayagaki et al., 2011)
cell death and subsequently triggers sterile inflammation in the surrounding
tissue when IL-1? binds to IL1R1 present on neighbouring cells (Chen et al.,
2007). In the case of apoptotic cell death, IL-1?  rapidly translocates to the
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nucleus and becomes tightly bound to chromatin and therefore cannot bind to
IL1R1 (Cohen et al., 2010). Unlike IL-1?, IL-1? is produced active and can
rapidly induce pro-inflammatory signalling cascades without any prior
processing. IL-1? on the other hand requires cleavage of pro-IL-1? by caspase-
1, which in turn needs to be activated by inflammasomes (Chapter 2.4). IL-1? is
an important mediator of inflammatory response and is furthermore involved in
a variety of cellular activities, including cell proliferation and differentiation, as
well as apoptosis.
IL-18 was originally described as an interferon (IFN)?-inducing factor
(Okamura et al., 1995). It is constitutively expressed by macrophages and DCs
as well as in epithelial cells, such as keratinocytes, and its activation undergoes
the same caspase-1-dependent pathway as IL-1?.
IL-33 amplifies innate immunity and inflammatory responses. It is
constitutively expressed or inducible in several cell types, among them
hematopoietic cells. IL-33 is biologically active without processing and
inactivated by caspase-1. It is released as a bioactive molecule after the disruption
of cell integrity during necrotic cell death or it can be secreted by unconventional
mechanisms.
IL-36 is a subfamily consisting of IL-36?, IL-36?, and IL-36?. They are
expressed by keratinocytes and other epithelial cell types, and induce the
production of proinflammatory cytokines and chemokines. IL-36 is involved skin
and lung pathology by both initiating and mediating inflammation (Towne et al.,
2011). IL-36 family members are known to act extracellularly, but they lack a
signal peptide which would target them to be secreted by ER/Golgi mediated
protein secretion pathway (Towne et al., 2011).
1.5.2 The TNF family
The  tumour  necrosis  factor  (TNF)  superfamily  consists  of  19  ligands  with
diversified roles in the body (Aggarwal et al., 2012). TNF was formerly known
as  TNF? and  is  by  far  the  best  studied  member  of  the  family.  TNF  itself  is
expressed in activated macrophages and can be induced in many other cells types.
TNF itself is a pro-inflammatory cytokine which activates the transcription factor
NF-?B (nuclear factor ?B) and mitogen-activated protein kinase (MAPK)
pathways and thereby upregulates the expression of many pro-inflammatory
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mediators such as chemokines, cytokines, adhesion molecules, and growth
factors. While the cytokine has been linked with several important protective
functions e.g. physiologic proliferation and differentiation of B cells under
steady-state conditions, it also has been associated with a variety of inflammatory
diseases, including cancer, cardiovascular, neurologic, pulmonary, autoimmune,
and metabolic disorders and TNF upregulation has been implicated in the
pathogenesis of several chronic inflammatory disorders. TNF is released from
cells through a process called ectodomain shedding, which is dependent on
ADAM metallopeptidase domain 17 (ADAM-17/TACE) (Black et al., 1997,
Moss et al., 1997). There are 29 known TNF family receptors.
1.5.3 Interferons
Interferons (IFNs) are cytokines which are named after their ability to ‘interfere’
with viral replication. Three IFN types have been described: type I IFNs (IFN-?
and IFN-?), one single type II interferon named IFN?, and type III IFNs which
consist  of IFN-?1- IFN-?4. All  IFNs are antiviral  agents and they all  share the
ability to modulate immune responses.
Type I IFNs are produced by pDCs, macrophages and epithelial cells as well
as by almost all cell types in response to activation by PRR signalling. They fulfil
several functions: they induce the transcription of IFN inducible genes and
thereby activate a cell-intrinsic antimicrobial state, both in infected cells as well
as after secretion, in neighbouring cells. They also promote antigen presentation
and Nk cell functions, and activate the adaptive immune system and regulate
immune cell recruitment by induction of chemokines (Ivashkiv and Donlin, 2014,
González-Navajas et al., 2012).
IFN? is produced mainly by Nk cells and T cells upon activation with IL-12;
it is a potent activator of effector functions in phagocytic cells. It also plays an
important role in the induction of adaptive responses by promoting antigen
processing and presentation in DCs (Frasca et al., 2008).
Type III IFNs are produced by most cell types upon activation by PRR
signalling. They regulate a similar set of genes as type I IFNs, but whereas type
1 IFNs act in a more global manner, IFN-?s primarily target mucosal epithelial
cells to protect them from viral attack and thus help to maintain healthy mucosal
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surfaces, without the significant immune-related pathogenic risk associated with
type I IFN responses (Wack et al., 2015).
1.5.4 Colony stimulating factors
The colony stimulating factors (CSFs) include granulocyte macrophage-CSF
(GM-CSF), macrophage-CSF (M-CSF or CSF-1), and granulocyte-CSF (G-
CSF). They are hematopoietic growth factors with diverse functions in both
homeostasis and inflammation (Hamilton and Achuthan, 2013). They were
originally defined by their respective abilities to generate different types of
myeloid populations from precursor bone marrow cells; GM-CSF can promote
the survival and activation of macrophages, neutrophils, and eosinophils, e.g. it
promotes the differentiation of monocytes into the inflammatory M1-type
macrophages. M-CSF directs the process towards generating M2 type
macrophages and is essential for the maintenance of tissue-resident macrophage
lineage populations and therefore crucial in the maintenance of tissue integrity.
Finally, G-CSF stimulates the growth of neutrophil progenitor cells and controls
neutrophil numbers. As regulators of inflammation, the CSFs have become
targets for therapeutic intervention in inflammatory, autoinflammatory, and
autoimmune diseases (Hamilton et al., 2017, Wicks and Roberts, 2016).
1.5.5 Chemokines
Chemokines are small, secreted proteins regulating the recruitment of immune
cells  to  the  site  of  injury  or  immune  response.  In  humans,  48  different
chemokines have been identified to date, and they are grouped based on their N-
terminal  structures  into  four  families:  CXC,  CC,  CX3C,  and  XC  (Striz  et  al.,
2014, Blanchet et al., 2012). They bind to specialized receptors on the cell
surface, which are grouped into four families according the chemokine family to
which they bind: CXCR, CCR, CX3CR, and XCR (Nomiyama et al., 2011).
Chemokines are involved in a variety of functions both in homeostasis and
under inflammatory conditions. They can be grouped into pro-inflammatory,
homeostatic, and dual-function chemokines. Pro-inflammatory chemokines are
up-regulated under inflammatory conditions and are involved in recruitment of
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leukocytes to sites of inflammation, and homeostatic chemokines are expressed
constitutively and are involved in homeostatic migration and homing of cells.
(Nomiyama et al., 2011, Blanchet et al., 2012).
1.6 Innate immune response to selected microbial pathogens
Microbial pathogens can be grouped into four broad categories: Viruses, bacteria,
fungi, and parasites. However, not all microorganisms belonging to these
categories are pathogens; some bacteria and fungi play critical roles in
maintaining the health of our gastrointestinal system and skin. Microorganisms
become pathogenic once they penetrate the barriers of the body and inflict cell or
tissue damage. In some cases microorganisms secrete toxins which inflict cell or
tissue damage and classifies them as pathogens. Upon entering the body different
pathogens are detected by PRRs and trigger distinct cellular and intercellular
responses, which differ in the signalling pathways involved but ultimately all
trigger inflammation in order to expel the microbial invader and initiate tissue
repair (Figure 6).
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Figure 6: Innate immune response to IAV and gram-negative bacteria-
derived LPS. Left: IAV can enter the cell by endocytosis. TLR7 is a PRR on the
endosomal membrane which can detect viral ssRNA and activate the
transcription  of  type  I  IFNs  and  IFN  inducible  gens  (ISGs).  The  virus  can
highjack the host cell translation machinery and replicate viral RNA, which is
detected upon leaving the nucleus by RIG-I on the membrane of mitochondria.
Right: Extracellular LPS is detected by transmembrane PRR TLR4, which
induces the transcription of NLRP3, pro-IL-1?, guanylate-binding proteins
(GBPs) and type I IFNs. Intracellular LPS can bind directly to caspase-4/5,
activating the non-canonical inflammasome which cleaves gasdermin D, the
truncated N-terminus creates pores in the cell membrane and thus induces an
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inflammatory cell death called pyroptosis. Caspase-4 can also proteolytically
activate IL-18.
1.6.1 Influenza A
Viruses  are  the  most  abundant  biological  entities  on  the  planet,  with  the  total
number of virus particles exceeding the number of cells by at least an order of
magnitude (Koonin et al., 2006). They are small pathogens which cannot
reproduce by themselves, but they infect other cells and exploit the host cell’s
ribosomal machinery for replication. Due to their vast genetic diversity, there are
several classification systems for viruses, one common approach is to order them
according to their genome. This classification system groups them into four
clusters: single-stranded RNA (ssRNA), double-stranded RNA (dsRNA), single-
stranded DNA (ssDNA), and double-stranded DNA (dsDNA).
Influenza  A  viruses  (IAVs)  are  negative-sense,  ssRNA  viruses  with  a
segmented genome. The 8 segments of the IAV genome encode for 11 proteins
(summarized in table 4) (Bouvier and Palese, 2008).
Table 4: Proteins of the influenza A virus.
Gene Protein Function
PB2 Polymerase basic protein 2 Polymerase subunit; mRNA caprecognition
PB1 RNA-directed RNApolymerase catalytic subunit Polymerase subunit; protease activity
PB1-F2 Protein PB1-F2 Pro-apoptotic activity
PA Polymerase acidic protein Polymerase subunit; protease activity
HA Hemagglutinin Surface glycoprotein; antigen, receptorbinding and fusion activities
NP Nucleoprotein RNA binding protein; nuclear importregulation
NA Neuroamidase Surface glycoprotein; sialidase activity,virus release
M1 Matrix protein 1 RNA nuclear export regulation, viralbudding
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Gene Protein Function
M2 Matrix protein 2 Ion channel; virus uncoating andassembly
NS1 Non-structural protein 1 Interferon antagonist protein; regulationof host gene expression
NEP/NS2 Nuclear export protein Nuclear export of RNA
The genome is packed into a viral structure called the virion, which is ~80-
120 nm in diameter and can be spherical or filamentous. There are many IAV
subtypes, which are named according to the number of hemagglutinin (H) and
neuroamidase (N) antigens on the virion surface.
IAV  is  able  to  infect  a  variety  of  avian  and  mammalian  species.  They  are
responsible for the annual epidemics that cause severe illnesses in millions of
people worldwide, being responsible for about 500,000 deaths annually and are
associated with considerable morbidity (Nicol and Dutia, 2014).
When infecting humans, the first barrier for the IAV to pass is the mucus
membrane which contains soluble glycoproteins rich in sialic acids, which are
cell receptors and bind IAV virions in an attempt to trap them (Cohen et al.,
2013). If the viral particle passes through, it infects the underlying tissue by
attaching itself onto the host cell membrane. The IAV envelope has so called HA
spikes containing a protein stem anchored in the virus envelope and a head region
which contains the sialic acid receptor binding site. Binding of the viral HA spike
to sialic acid triggers endocytosis of the virion. The virus benefits from the low
pH within the endosome which facilitates uncoating of the virus and the merging
of the viral envelope with the endosomal membrane which opens a pore through
which the viral genome is released into the host cell cytoplasm. From there the
viral RNAs are trafficked to the host cell nucleus where the replication occurs.
The freshly synthesized viral components are trafficked to the cell membrane for
virion assembly. In productive infections, the virion then buds from the cell
membrane but stays attached by HA spikes to the cell until it is actively released
by the sialidase activity of the NA protein (Bouvier and Palese, 2008).
Viruses within the endosomes are detected by TLR3 and TLR7/8, and in the
cytoplasm directly by Rig-I and indirectly by NLRP3, activating the secretion of
type I IFNs, pro-inflammatory cytokines, and chemokines. The IFNs induce an
antiviral state in the neighbouring cells by promoting the transcription of IFN-
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inducible genes, the pro-inflammatory cytokines and eicosanoids cause local and
systemic inflammation, and activate the adaptive immune system. Chemokines
recruit neutrophils, monocytes and NK cells to the site of the infection and
subsequently, the phagocytic monocytes and neutrophils help to clear infected or
dead cells (Iwasaki and Pillai, 2014) .
If the virus nevertheless is able to establish an initial infection, IAV
subsequently spreads to local immune cells, including macrophages. Upon
activation, macrophages secrete not only cytokines, but a variety of other
biomolecules such as proteins, nucleic acids, and lipids that play important roles
in intercellular signalling.
1.6.2 Gram-negative bacteria
Bacteria are small prokaryotic microorganisms. There are several ways to
classify bacteria, one of the oldest is the Gram staining technique which was
published 1884 by Hans Christian Gram and is still used today. The staining
divides bacteria into two subgroups according to their cell wall structure: Gram-
positive and gram-negative bacteria. Gram-positive bacteria possess a thick cell
wall which can be stained; gram-negative bacteria have a thin cell wall enclosed
by a second lipid membrane containing endotoxic LPS and lipoproteins.
However, not all bacteria can be classified by this technique.
LPS represents a family of glycolipids consisting of a highly conserved lipid
moiety called lipid A. In most forms, lipid A becomes glycosylated by addition
of an oligosaccharide that in some bacteria, provides an attachment site for long
chains of polysaccharides. LPSs are produced by most gram-negative bacteria;
they play important roles in the integrity of the outer-membrane and participate
extensively in the host–pathogen interaction, contributing to the cytotoxicity of
LPS (Whitfield and Trent, 2014).
Extracellular LPS is recognized by TLR4, which induces the transcription of
genes encoding cytokines, chemokines, and co-stimulatory molecules in antigen
presenting cells; this results in the activation of the anti-microbial defence and
adaptive immune response. Intracellular LPS is recognised by the non-canonical
inflammasome and activates both the NLRP3 inflammasome and triggers
pyroptosis. Infections with gram-negative bacteria are associated with an array
of diseases including pneumonia, bloodstream infections, wound infections,
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meningitis, as well as several sexually transmitted diseases. Infection can also
lead to the life-threatening condition called endotoxic shock or sepsis,  which is
one of the major causes of death in intensive care units (Angus  and van der Poll
2013).
One of the main reasons for the rapidly growing interest in gram-negative
bacteria is antibiotic resistance; i.e. although all bacteria have an inner cell
membrane, gram-negative bacteria have a unique outer membrane which
prevents certain drugs and antibiotics from penetrating the cell, partially
explaining why gram-negative bacteria are generally more resistant to antibiotics
than their gram-positive counterparts (Miller, 2016).
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2 Mass spectrometry-based secretome analysis
The proteome is the entirety of all proteins expressed by a genome, cell, tissue,
or organism at a certain time. The term was coined in 1994 by Marc Wilkins in a
symposium on "2D Electrophoresis: from protein maps to genomes" held in
Siena, Italy, and in 1995 published in a paper which was a part of his PhD thesis
(Wasinger et al., 1995). Consequently, proteomics has been viewed as the large-
scale study of proteins and their functions. Early MS-based proteomics analysis
gave rise to many hopes and expectations, but twenty years ago the methods and
instrumentation needed for sensitive high-throughput proteome analysis were not
mature enough to live up to the expectations (Huber, 2003). Since then, mass
spectrometry (MS)-based proteomic techniques and instruments have rapidly
evolved and subsequently, proteomics have started to make major contributions
to biomedical research.
Secretomics describe the global study of proteins secreted by a cell, tissue, or
organism at a given time or under certain conditions. As the secretome contains
proteins that control and regulate a multitude of biological and physiological
processes, it is a source for biomarkers and therapeutic target discoveries
(Hathout, 2007). The majority of secretome studies have been performed in
cancer biology, however, in the past five years, secretomics has been proven to
be increasingly valuable in immunology as well (reviewed in (Nyman et al.,
2017)).
2.1 GeLC-MS/MS
There is no standardized proteomics workflow; different investigators utilize
different approaches, depending on the underlying biological question, the
instrumentation, and the biological starting material.
In the GeLC-MS/MS workflow, proteins are fractionated based on their size
using SDS-PAGE gel electrophoresis and this is followed by identification of all
proteins in the gel lane by MS. MS is an analytical technique that measures the
mass-to-charge ratio (m/z) of ionized molecules in the gas phase. In the
identification, proteins are digested with specific enzymes like trypsin, and the
resulting peptides are analysed by MS. There are two main ionization techniques
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for biomolecules, matrix-assisted laser desorption and ionization (MALDI)
(Karas et al., 1985), and electrospray ionization (ESI) (Dole et al., 1968). The
2002 Nobel Prize in Chemistry was awarded jointly to Koichi Tanaka and John
Fenn ”for their development of soft desorption ionization methods for mass
spectrometric analyses of biological macromolecules”, which have greatly
advanced the analysis of proteins by mass spectrometry. As ESI ionizes the
analytes  present  in  a  solution,  it  is  most  commonly  coupled  to  liquid
chromatography (LC) to separate peptides based on their interactions with the
column resin, while MALDI desorbs and ionizes the samples out of a crystalline
matrix via laser pulses. The gas phase ions are then directed to a mass analyser,
where they are separated based on their m/z value and accelerated to the detector
where they are detected and converted to a digital output. In the case of tandem
mass spectrometry (MS/MS), specific masses can be selected in the mass
analyser and directed to a collision cell where they are collided against
accelerated gas atoms to further fractionate them before recording the fragment
spectra.
The whole GeLC-MSMS workflow comprises of several steps including
sample preparation and fractionations, LC-MS/MS, database searches for
identification of proteins, and bioinformatic assessment of the results
(Dzieciatkowska et al., 2014) (Figure 7).
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Figure 7: GeLC-MS/MS workflow. In the first step, the sample material is
collected, separated from its biological matrix, and optionally further
fractionated. The proteins are denatured, separated based on their size by SDS-
PAGE, and optionally visualised by gel staining. The gel lanes are cut into pieces,
the proteins are reduced, alkylated, and enzymatically digested by trypsin. The
resulting peptides are eluted from the gel matrix, de-salted, solubilized in a weak
acid and injected into the LC system where they are further separated based on
their polarity in a reverse-phase column. From the LC system, the peptides are
injected into the mass spectrometer, ionized, and their mass-to-charge ratio is
analysed and transformed into a digital output. For identification or quantitation,
several computational algorithms have been developed to match peptide
fragmentation spectra to in-silica spectra of peptides to aid in the identification
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of the corresponding protein. These MS/MS spectra are quantified and searched
against a database to identify the proteins from they originated. This final protein
lists are further analysed with bioinformatic tools.
2.2 Bioinformatic tools
Once lists of identified and quantified proteins are established, a variety of
possible bioinformatics tools and software can be used to analyse and visualize
the data, compare samples and sample groups, and confer context to these
findings (Carnielli et al., 2015, Karimpour-Fard et al., 2015, Wu et al., 2014).
The Gene Ontology (GO) initiative classifies gene or gene product functions
by their molecular function, cellular component, or by the biological process in
which they are involved (Ashburner et al., 2000). Analysing the GO terms which
are enriched in a given dataset allows interpretation of the biological state or the
originating sample. The Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway database hosts more than 90?000 pathways and is a collection of pathway
maps representing current knowledge on molecular interactions and reaction
networks related to metabolism, cellular processes, organismal systems, human
diseases etc. It allows pathway mapping of large-scale molecular datasets from
genomics, transcriptomics, proteomics, and metabolomics, and thus is beneficial
in the biological interpretation of higher-level systemic functions (Kanehisa et
al., 2012). Ingenuity® Pathway Analysis (IPA®) is a canonical pathway tool that
enables analysis, integration, and understanding of data from gene expression,
miRNA, and SNP microarrays, as well as metabolomics, proteomics, and
RNAseq experiments (Krämer et al., 2014).
Enrichment analysis is a popular method for analysing gene sets generated by
genome-wide experiments (Kuleshov et al., 2016). EnrichR is a free browser-
based tool which currently contains 180 184 annotated gene sets from 102 gene
set libraries (Chen et al., 2013).
In order to visualize lists of identified proteins based on their function, the
PANTHER (Protein ANalysis THrough Evolutionary Relationships)
classification system can be used; this is a comprehensive, curated database of
protein families, trees, subfamilies and functions. Protein families are groups of
evolutionarily related proteins; subfamilies are related proteins that also possess
the same function. The function of the protein by itself or with directly interacting
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proteins is classified at a biochemical level, e.g. protein kinase. The function of
the protein in the context of a larger network of proteins that interact to
accomplish a process at the level of the cell or organism is classified in biological
processes,  such  as  pathways,  which  additionally  explicitly  specify  the
relationships between the interacting molecules. The PANTHER Classifications
are the result of human curation as well as bioinformatics algorithms (Thomas et
al., 2003, Mi et al., 2013).
If one wishes to elucidate protein interactions, then the Search Tool for the
Retrieval of Interacting Genes/Proteins (STRING) database is a useful tool; this
aims to collect and integrate knowledge of all functional interactions between the
expressed proteins, by consolidating known and predicted protein–protein
association data for a large number of organisms. The associations in STRING
include direct (physical) interactions, as well as indirect (functional) interactions.
Interaction predictions are derived from 1) systematic co-expression analysis, 2)
detection of shared selective signals across genomes, 3) automated text-mining
of the scientific literature as well as 4) computational transfer of interaction
knowledge between organisms based on gene orthology (Szklarczyk et al., 2017,
Szklarczyk et al., 2015).
Several freely available EV databases and tools exist to analyse specifically
secretome data, the most up-to-date ones being ExoCarta and Vesiclepedia.
ExoCarta is an online exosome database that catalogues exosome specific data
pertaining to proteins, RNAs and lipids. ExoCarta contains annotations on the
isolation and characterization methods (Keerthikumar et al., 2016). Vesiclepedia
is a manually curated compendium of lipids, RNAs, and proteins identified in
different classes of EVs from more than 300 independent studies published over
the past few years (Kalra et al., 2012). Proteins secreted by conventional ER-
Golgi secretion carry an N-terminal signal peptide. SignalP is a web-based server
predicting the presence and location of signal peptide cleavage sites in amino
acid sequences from different organisms such as Gram-positive prokaryotes,
Gram-negative prokaryotes, and eukaryotes (Petersen et al., 2011).
2.3. Secretomics of pathogens
Pathogens have developed very specific tactics of circumventing immune
responses, and they can employ different secretory systems. For example,
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bacterial pathogens employ several secretory systems to secrete proteins across
phospholipid membranes that can play many roles in promoting bacterial
virulence, such as enhancing attachment to eukaryotic cells and attacking target
cells to disrupt their functions (Green and Mecsas, 2016). Parasitic helminths
secrete immunomodulating products which act as local anti-inflammatory agents
(Harnett, 2014), and fungi secrete hydrolases which have been proposed to
facilitate active penetration into host cells and enhance the efficiency of
extracellular nutrient acquisition (Mayer et al., 2013).
The elucidation of the whole secretomes (WS) and EVs of pathogenic
bacteria, fungi, and parasites has led to the identification of new virulence factors,
vaccination candidates, biomarkers, therapeutic intervention possibilities, and
given new insights about pathogenic secretory systems (Table 5).
Table 5: Selected pathogen secretome studies.
Pathogen Sample Finding Reference
Candida albicans EV EVs carry classical
cytoplasmic proteins
(Gil-Bona et al.,
2015)
Cryptococcus
neoformans
WS Regulation of virulence-
associated proteins and
potential biomarkers by
protein kinase A
(Geddes et al.,
2015)
Escherichia coli WS Type III secretome includes
an expanded effector
repertoire for
attaching/effacing bacterial
pathogens
(Deng et al., 2012)
Escherichia coli WS Comparison of pathogenic
vs. non-pathogenic E. coli
secretomes reveals
differential expression of
virulence factors
(Boysen et al.,
2015)
Fasciola hepatica EV Analysis of EV biogenesis
pathways and cargo involved
in pathogenesis
(Cwiklinski et al.,
2015)
Helicobacter pylori WS Growth phase-dependent
exoproteome composition
(Snider et al.,
2016)
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Pathogen Sample Finding Reference
Leishmania EV Absence of metalloprotease
GP63 alters the protein
content of EVs
(Hassani et al.,
2014)
Listeria
monocytogenes
WS Involvement of  type I signal
peptidases in secretion and
insights into bacteria
physiology
(Renier et al.,
2015)
Mycobacterium
tubercolosis
WS Antigen 85 variation across
lineages impacts vaccine and
biomarker success
(Kruh-Garcia et al.,
2014)
Mycobacterium
tubercolosis
WS Hypervirulent strain
produces increased amounts
of EsxB and proteins
involved in adaptation to
intracellular lifestyle
(Vargas-Romero et
al., 2016)
Pseudomonas
aeruginosa
EV Post-transcriptional regulator
modulates the generation of
EVs and secreted virulence
factors
(Reales-Calderón
et al., 2015)
Stenotrophomonas
maltophilia
EV EVs of a clinical isolate and
a collection strain reveal
differences involving
pathogenesis, virulence and
resistance proteins
(Ferrer-Navarro et
al., 2016)
Streptococcus
pneumoniae
EV EVs carry surface proteins
and virulence factors, they
are  immunoreactive against
human sera and induce
immune responses
protecting against infection
(Olaya-Abril et al.,
2014)
Streptococcus
pneumoniae
WS New approach reveals a
novel secreted antigen
(Choi et al., 2012)
Streptococcus
pyogenes
WS A novel acid-induced protein
histidine triad protein A is
involved in necrotizing
fasciitis
(Wen et al., 2014)
Vibrio cholarae WS Type VI secretion system
analysis reveals a new
effector-immunity pair
(Altindis et al.,
2015)
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2.4 Secretomic studies of host cell response
In vitro studies can be useful in elucidating the interactions between host cells
and pathogens. Upon stimulation, cells secrete proteins via diverse secretion
pathways, and understanding these pathways can be a key to therapeutically
mediate inflammatory responses.
Current proteomics methods and instrumentation allow for highly sensitive
secretome analysis. This is exemplified by a 2013 study in which Meissner and
co-workers achieved low picogram sensitivity when quantifying the time-
resolved release of 775 proteins, including 52 annotated cytokines from only
150,000 primary TLR4-activated macrophages (Meissner et al., 2013). Another
example is a very recent publication which analysed 28 different human
hematopoietic cell types and identified different communication structures used
by myeloid and lymphoid immune cells enabling the authors to define the social
network architecture of immune cells and to provide a proteome atlas;
furthermore with the help of extensive data mining, it was possible to characterize
the architecture of intercellular crosstalk, providing a systems biology reference
framework of intercellular signalling (Rieckmann et al., 2017).
A notable example of studying the basics of protein secretion in immunology
is the extensive proteomic characterization of different EV classes secreted from
DCs. The EVs were separated using several complementing techniques, and
proteomics analysis identified proteins specifically enriched in small EVs and
enabled the authors to define a set of five protein categories displaying different
relative abundances in distinct EV populations. The study also revealed that
several classically used exosome markers are similarly present in all EVs, and
therefore indicated that these novel protein markers could be useful in
distinguishing different EV sub-populations (Kowal et al., 2016).
EV secretion from cells in a stress or disease state has been studied, resulting
in new insights about the effects of EVs on surrounding tissue. Mast cell
degranulation has often been studied as an example of this phenomenon.
Degranulation is a process where antigens bind to IgE antibodies on the cell
surface of granulocytes or mast cells to induce the release of antimicrobial
compounds from cytoplasmic granules. The study revealed that during their
degranulation mast cells release EVs containing mast cell-specific proteases.
These EVs and their content are potentially important immune regulators (Groot
Kormelink et al., 2016). In another study, atherosclerosis was studied by
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examining unconventional protein secretion from foam cells, which are fat-laden
macrophages embedded inside atherosclerotic plaques. The secreted EVs were
able to promote vascular smooth muscle cell migration and adhesion, and thereby
potentially modulate disease progression (Niu et al., 2016).
NLRP3 inflammasome activation is one of the main inducers of protein
secretion and a selection of its activators such as the DAMP ATP, crystals such
as monosodium urate (MSU), and TLR stimulating adjuvants have been used to
stimulate cells and analyse the conditioned media to gain further understanding
of immune response, protein secretion, and their modulators (Table 6). A large
part of secretomics-proteomics studies focus on secretion from infected cells,
with the stimulus used being viral, bacterial such as life bacteria or cell wall
components e.g. LPS, or fungal such as Candida albicans or the fungal cell wall
component ?-glucan (Table 6). Many pathogenic species have co-evolved with
their mammalian hosts over millions of years and developed various strategies to
attenuate the host cell’s immune responses.
The discoveries provided by these studies shed new light not only on the roles
of EVs in the pathogenesis of infectious diseases, but they have also identified
new biomarkers, virulence factors, and immune regulatory pathways affected by
EVs.
In the case of viral infections, EV pathways were identified that directly
facilitated virus survival and spreading. Furthermore, these studies have revealed
pathways  of  host  response  such  as  secretion  of  IFNs  to  prime  surrounding
uninfected cells, secretion of DAMPs and PAMPs, and secretion of ribosomal
proteins to inhibit translation. Studies of host response to bacterial infection have
confirmed the presence of strain-to-strain differences in bacterial virulence and
inflammatory responses, and introduced new insights about the role of EVs in
disease pathogenesis.
Table 6: Secretome analyses of immune cells upon activation
Stimulus Host cell Sample Finding Reference
ATP Macrophages WS
Inflammasome
activation and EV
secretion are calpain-
dependent
(Valimaki et
al., 2016)
MSU Macrophages WS EV secretion iscathepsin-dependent
(Valimaki et
al., 2013)
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TNF hASCs WS
Secreted factors drive
monocyte migration
and tissue regeneration
(Lee et al.,
2010)
Adjuvants Monocytes WS
Secretomes differ
depending on adjuvant
type and the age of the
study participant
(Oh et al.,
2016)
Virus Host Cell Sample Finding Reference
IAV Macrophages WS
DAMP secretion,
P2X7 receptor and
SRC tyrosine kinase-
dependent
inflammasome
activation
(Lietzen et
al., 2011)
HSV-1 Macrophages WS Secretion of IFN-induced proteins
(Miettinen
et al., 2012)
HIV-1 H9 cells EVs
EVs contain regulatory
molecules that impact
cellular apoptosis and
proliferation
(Li et al.,
2012)
HIV-1 Macrophages EVs
EVs facilitate transfer
of HIV-1/viral
constituents from
infected to
neighbouring
uninfected cells
(Kadiu et
al., 2012)
KSHV,EBV,
both B cell lines EVs
Virus- and host cell-
specific modifications
of the EV proteome in
correlation and
dependent on the
expression of viral
oncogene latent
membrane protein-1
(Meckes et
al., 2013)
HBV Huh 07 EVs
Virus infection alters
the proteomic
composition of  EVs
(Zhao et al.,
2014)
HTLV-1 T-cell lines EVs Virus proteins andmRNA secretion
(Jaworski et
al., 2014)
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Bacteria Host Cell Sample Finding Reference
Staphylococcus
aureus
Various
immune cells WS
Differences in
inflammatory
responses induced by
different strains
(Strobel et
al., 2016)
Streptococcus
pyogenes Neutrophils WS
A novel secreted
streptococcal factor
(Uhlmann et
al., 2016)
LPS Endothelialcells WS
19 potential
biomarkers for sepsis
(Kwon et
al., 2015)
Mycobacterium
tuberculosis Macrophages EVs
EVs from infected
macrophages contain
several IFN-inducible
proteins
(Hare et al.,
2015)
Mycobacterium
avium THP1 cells EVs
EVs from infected
cells contained
components that
induced immune
responses in resting
cells, suggesting an
important function for
EVs in anti-
mycobacterial host
defence.
(Wang et
al., 2014)
Fungus Host Cell Sample Finding Reference
?-glucan Macrophages EVs
Secretion of cation-
dependent mannose-6-
phosphate receptor,
macrophage scavenger
receptor, P2X7
receptor, and several
integrins
(Cypryk et
al., 2014)
Candida
albicans THP1 cells EVs
Secretion of signalling
proteins including
chitinase-3-like protein
1, potentially the
component responsible
for the pro-
inflammatory
properties of the
secreted EVs
(Reales-
Calderon et
al., 2016)
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?-glucan Macrophages WS
EV secretion triggered
by the dectin-1
pathway, is dependent
on inflammasome
activity and an active
autophagic process
(Ohman et
al., 2014)
hASCs = Human adipose tissue-derived mesenchymal stem cells, KSHV= Kaposi
sarcoma-associated virus, EBV=Epstein-Barr virus, HBV = Hepatitis B virus, HTLV-1 = Human
T-lymphotropic virus type 1
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II Aims of the study
The main goal is the unravelling of the response of human macrophages after
inflammasome activation with the focus on conventional and unconventional
protein secretion using proteomics combined with bioinformatics and functional
studies. Different stimuli such as influenza A virus and the gram-negative
bacterial cell wall component lipopolysaccharide (LPS) were applied to activate
both non-canonical and NLRP3 inflammasomes, and the resulting protein
secretion was examined in detail.
The specific aims were:
I. to investigate vesicle-mediated protein secretion of human macrophages in
response to viral infection  using proteomics tools
II. to characterise protein secretion of human macrophages in response to
intracellular LPS recognition and non-canonical inflammasome activation
using quantitative proteomics
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III Materials and methods
3 Cell Culture
Peripheral blood mononuclear cells were isolated from healthy blood donors
(Finnish Red Cross Blood Service) by low-speed density gradient centrifugation
over Ficoll-Paque Plus (Amersham Biosciences, Uppsala, Sweden) as previously
described (Pirhonen et al., 1999). The cells were then plated and allowed to
adhere to culture plates in RPMI media supplemented with 0.6 ?g/ml penicillin
and 60 ?g/ml streptomycin (Life Technologies, Paisley, UK) and U-glutamine
(Lonza, Basel, Switzerland) in 37ºC, 5% CO2. After 1 hour, unattached cells were
washed three times with PBS and the plastic-adhered monocytes were cultured
for 6 days in Macrophage-SFM medium (Life Technologies) supplemented with
10  ng/ml  GM-CSF  (Biosource  International,  Camarillo,  CA)  and  antibiotics,
including 0.6 ?g/ml penicillin and 60 ?g/ml streptomycin (Life Technologies)
allowing them to differentiate into macrophages. When culturing M-CSF
macrophages, GM-CSF was replaced with 50 ng/ml recombinant human M-CSF
(ImmunoTools, Friesoythe, Germany).
3.1 Cell stimulations and infections
3.1.1 IAV infections
On day  six  of  culturing,  the  cells  were  washed  with  PBS,  supplied  with  fresh
RPMI 1640 medium (Gibco) supplemented with L-glutamate and antibiotics, and
incubated at 37°C, 5 % CO2. The cells were subsequently infected with human
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pathogenic influenza A (H3N2) strain Udorn/72 (2.56 hemagglutination
unit/mL) for the times indicated.
3.1.2 LPS transfections
On day six after monocyte isolation, the cells were washed with PBS, supplied
with fresh RPMI 1640 medium (Gibco) supplemented with L-glutamate and
antibiotics and subsequently mock-transfected or transfected with Ultrapure LPS
(Invivogen, E.coli 0111:B4 1mg/mL) using Lipofectamine 2000 (Invitrogen,
Thermo Fisher Scientific, Carlsbad, CA, USA) for the times indicated.
3.1.3 Inhibitors
Caspase-4 inhibitor (Z-YVAD-FMK, 25 ?M) was purchased from R&D Systems
(Minneapolis, US) and when it was used, it was added to the media 1 h prior to
LPS transfection.
3.1.4 Silencing methods
On day 5 of cell culturing in 12-well plates, macrophages were transfected with
100 nM non-targeting control siRNA (AllStars Negative Control siRNA, Qiagen,
Hilden,  Germany)  and  with  50  nM  each  of  two  GAPR-1  siRNAs  (FlexiTube
siRNA 5nmol, Qiagen: Hs_C9orf19_8, Hs_C9orf19_6; final concentration = 100
nM) using HiPerFect Transfection Reagent (Qiagen), according to the
manufacturer’s instruction. After 3 h of siRNA treatment, cells were
supplemented with fresh macrophage-SFM. On the following day, the siRNA
treatment was repeated.
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3.2 EV isolation and secretome enrichment
In the EV isolation in study I, cell culture supernatants were collected and
centrifuged at 350 g for 6 min to remove any suspended cells and further at 3,000
g  for  30  min  to  remove  residual  cell  debris.  After  this,  the  cell  culture
supernatants were concentrated through Amicon 100 kDa MWCO centrifugal
filter units (Millipore) and EVs were isolated by ultracentrifugation as previously
described (Cypryk et al., 2014). In brief, the concentrated media were transferred
to 5 mL ultracentrifugal polyallomer tubes (Beckman),  which were filled with
PBS and centrifuged for 1 h at 4 °C at 100?000g in SW 55 Ti swinging bucket
rotor (Beckman Coulter). The supernatants were removed gently with a pipette
and the EV pellets were resuspended in 5 mL of fresh PBS. The tubes were
centrifuged at 100?000g for additional 1 h. The pellets were resuspended in
Laemmli sample buffer before SDS-PAGE.
For EV enrichment in I and II, the conditioned media were concentrated 50-
100-fold by size-exclusion centrifugation through Amicon 100 kDa MWCO
centrifugal filter units (Millipore). For the rest secretome, the flow-through was
concentrated 50-100-fold on 10 kDa MWCO centrifugal filter units (Millipore).
In the total secretome enrichments, the conditioned media were centrifuged
at 350 g for 6 minutes to remove detached cells and cell debris and subsequently
concentrated 50-100-fold by size-exclusion centrifugation through 10 kDa
MWCO centrifugal filter units (Millipore). The volumes of the concentrated
secretome fractions were equalized with PBS.
3.3 Protein identification and quantitation by GeLC-
MSMS
In the MS analysis of isolated EVs or enriched secretome fractions, the samples
were denatured in Laemmli sample buffer and the proteins were separated by
SDS-PAGE.
The proteins were identified using GeLC-MS/MS as previously described
(Savijoki et al., 2011). Briefly, the proteins were separated by SDS-PAGE, silver
stained (O'Connell and Stults, 1997) and the gel lanes were cut into 5-6 pieces.
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The  proteins  were  reduced  with  20  mM  dithiotreitol  for  30  min  in  56  °C,
alkylated with 55 mM iodoacetamide for 15 min in the dark, and in-gel digested
with trypsin (Promega) overnight in 37 °C. The peptides were eluted twice with
0.1  %  FA/50  %  ACN,  dried  and  solubilized  in  0.1  %  FA  prior  to  mass
spectrometry analysis.
Each peptide mixture was analysed on an Easy nLC1000 nano-LC system
connected to a quadrupole Orbitrap mass spectrometer (QExactive,
ThermoElectron, Bremen, Germany) equipped with a nano-electrospray ion
source (EasySpray/Thermo). The resulting MS raw files were transferred to
Proteome Discoverer™ (Thermo Scientific™) using Mascot (Matrix Science)
search engine to match against SwissProt database (November 2015) in study I,
and with the MaxQuant software version 1.5.3.8 using the Andromeda search
engine in study II.
3.4 Biochemical methods
3.4.1 Western blotting
Equal volumes of concentrated media or 15-30 ?g of protein from cell  lysates
were used for immunoblotting. The protein samples were denatured in Laemmli
sample  buffer  containing  ?-mercaptoethanol  or  DTT  at  95°C  for  5  min  and
separated on SDS-PAGE, transferred to Immobilon-P Transfer Membranes
(Millipore), blocked with 5 % non-fat milk solution in TBS-Tween (TBS-T) and
incubated overnight at 4 °C with primary antibodies. The membranes were
washed 3 times with TBS-T and incubated with the appropriate HRP-conjugated
secondary antibody for 1 h at room temperature and subsequently washed with
TBS-T and visualized with Western Lightning ECL (Perkin-Elmer, Waltham,
MA).
The following Abs were used:
Antibody Vendor Study
Alix Santa Cruz Biotechnology I, II
Annexin-1 Santa Cruz Biotechnology I, II
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Galectin-3 Santa Cruz Biotechnology II
GAPDH Santa Cruz Biotechnology I
ITGAX Abcam PLC I, II
P-elF2? Cell Signaling Technologies II
Secondary Abs Dako Denmark A/S I, II
3.4.2 Luminex
The human cytokine Luminex Bio-Plex Pro immunoassay kit designed to detect
cytokines IL-1?, IL-1?, IL-18, and TNF were from Bio-Rad Laboratories
(Hercules, CA, USA). The Luminex assay was performed according to the
manufacturer’s instructions using Bio-Plex 200 system hardware and version
4.1.1 of Bio-Plex 200 software.
3.4.3 LDH assay
Lactate dehydrogenase (LDH) release is a hallmark for necrotic and pyroptotic
cell  death.  The  LDH  release  of  cells  was  measured  using  the  Cytotoxicity
Detection Kit (LDH) (Roche Diagnostics, Switzerland) according to the
manufacturer’s instructions.
3.4.4 Electron microscopy
Isolated EV pellets were suspended in a solution of 2 % PFA in PBS  to fix the
EVs, 5 μL of the suspension was transferred to Pioloform-carbon-coated copper
grids and allowed to absorb for 20 minutes. The grids were subsequently washed
and contrasted with uranyl acetate, embedded in a mixture of uranyl acetate and
methyl cellulose and dried. EVs were observed at 80 kV in a Jeol JEM-1400
transmission electron microscope in the Electron Microscopy Unit, Institute of
Biotechnology, University of Helsinki.
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IV Results and discussion
Macrophages are phagocytes and antigen-presenting cells (APCs) which play a
major role in the innate immune response to microbial infections. They respond
to microbial stimuli in various ways, including upregulated protein secretion
exploiting both conventional and unconventional secretion pathways. These
secretomes can be analysed in-depth by MS-based proteomics, allowing insights
into intercellular communication and cellular response mechanisms triggered by
microbial infection.
In  studies  I  and  II,  GM-CSF  macrophages  were  infected  with  IAV  or
transfected with LPS, and the resulting protein secretion was analysed using
GeLC-MS/MS combined with extensive bioinformatics; subsequently functional
experiments were conducted to follow up the resulting leads (Figure 8). In study
I, EVs from infected and control cells were isolated by ultracentrifugation and
GeLC-MS/MS was  performed to  identify  proteins  in  the  EVs.  In  study  II,  the
whole secretome was analysed, fractionated into an EV enriched fraction and the
soluble rest-secretome, EVs were enriched by size exclusion centrifugation at a
100 kDa cut-off,  and  the  flow through was  also  concentrated  and  analysed.  In
study II, GeLC-MS/MS workflow proteins were identified and quantified using
label-free quantitation.
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Figure 8: Study designs of studies I and II. Study I focused on the isolation of
EVs from IAV infected and non-infected macrophages 9 hours post-infection.
The EVs were analysed using GeLC-MS/MS resulting in the identification of 149
and 1060 proteins unique to the control and IAV samples, respectively. In all,
1299 proteins were identified in both datasets. In study II, macrophages were
mock-transfected or transfected with LPS for 1.5 hours, the whole secretome was
collected and fractionated by size exclusion filtration into either EV enriched or
rest-secretome fractions. The fractions were analysed with the GeLC-MS/MS
workflow, the enriched EV fractions contained 408 unique proteins, the RS
fractions 583 proteins, and 640 proteins were identified in both fractions. From
the 408 EV proteins, 48 were at least 2-fold upregulated after LPS transfection in
at least 2 out of 3 biological replicates, 36 proteins fulfilled these criteria in the
RS fractions.
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4.1 Unravelling the macrophage secretome
MS-based proteomics allows global protein identification as well as  systematic
profiling of dynamic proteomes (Zhang et al., 2013). In humans, more than
100,000 proteins are encoded by slightly over 20,000 genes. The major difference
is attributed to isoforms and splicoforms; several proteins can be encoded by the
same gene, and RNA splicing mechanisms make it possible to select different
protein-coding segments or even different parts from those to form different
mRNA sequences which are then translated into proteins. Additionally, the
proteome is highly dynamic; therefore proteomics datasets are more complex and
more detailed than their genomic counterparts.
Studies I and II resulted in sizeable datasets comprising thousands of
identified  proteins.  There  are  many  freely  available  tools  to  assist  in  the
functional interpretation of these very large proteomics datasets (Malik et al.,
2010). In studies I and II, the enrichment tool EnrichR was used to submit the
data to GO and KEGG pathway analysis databases. Complementary, several
separate pathway analysis tools such as PANTHER and the commercial  IPA®
were exploited to interpret the data. In order to gain insights into the interactomics
within the datasets, the data was examined in the protein-protein interaction
database STRING which allows the visualization of protein interactions within a
dataset or beyond to visualize clusters and functional complexes. Furthermore,
SignalP was used to establish whether the identified proteins carried a signal
peptide, and Vesiclepedia was utilised to verify if proteins had been previously
identified in EVs.
 There are a few considerations to be borne in mind when using these or other
bioinformatics tools:
Enrichment tools like EnrichR allow submitting a dataset through one web
interface to a number of different and complementing databases, but this and
other  enrichment  analysis  tools  still  use  gene  identifiers.  Hence  it  is  useful  to
submit the dataset as a protein identifier separately and directly to selected
pathway analysis sites and compare the resulting enrichment sets with EnrichR
data.
 The GO annotation has also some aspects that need to be considered: Firstly,
GO analysis is gene-centric. There are five times more gene products than genes
in the human body, and transcripts from one gene can vary in terms of both
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structure and function. The proteome is therefore a much more detailed snapshot
of the current situation in an experiment than can be obtained from evaluating the
expressions of mRNA. Thus, GO terms use simplified data to promote functional
understanding. Furthermore, most GO annotations are done computationally,
with only a minority being manually curated and based on experimental details
(Yon Rhee et al., 2008). In contrast, pathway databases are most often manually
curated but coverage and biological focus varies between them, making it
advantageous to run analyses through several platforms. Another aspect is that
these databases use different pathway names and identifiers which might differ
significantly from platform to platform. Despite these potential drawbacks, GO
annotation and enrichment analysis combined with pathway analysis are still the
most valuable tools for extracting biologically valuable information from large
datasets.
In conclusion, GO-, enrichment-, and pathway analyses are important and
valuable tools for making biological sense of large identification lists, but their
limitations should be kept in mind.
4.1.1 Analysis of EVs from human macrophages upon IAV infection
Study I analysed the isolated EVs from macrophages which were IAV- or mock-
infected for 9 hours. The time point was based on kinetic studies and offered a
maximal EV secretion with minimising interference from apoptosis i.e. avoiding
the appearance of apoptotic blebs in the EV isolates (Study I, supplemental figure
1A).
A total of 2359 proteins were identified from the EVs of infected cells; 1060
of these were unique. In contrast, 1448 proteins with 149 unique forms were
detected from control EVs. Overall, 1299 of these proteins could be identified in
both cell treatment groups (Figure 8, table 7).
Table 7: Bioinformatics overview of study I
CTRL IAV
Total IDs 1448 2359
Vesiclepedia 1351 2129
SignalP 371 532
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CTRL IAV
Top 3 KEGG pathways
Phagosome Phagosome
Endocytosis Ribosome
Proteasome Endocytosis
Top 3 GO: Biological Process terms
Antigen processing and presentation Gene expression
Antigen processing and presentation
of peptide antigen
Translation initiation
Antigen processing and presentation
of exogenous antigen
Antigen processing and
presentation
Top 3 GO: Molecular Function terms
GTPase activity GTP binding
GTP binding Guanyl nucleotide binding
Guanyl nucleotide binding GTPase activity
Top 3 GO: Cellular Component terms
Extracellular vesicular exosome Extracellular vesicular
exosome
Cytosol Cytosol
Anchoring junction Focal adhesion
From the 1448 proteins in the control set, 1351 had been identified previously
in EVs and were listed in Vesiclepedia; similarly from the 2359 IAV proteins,
the vast majority (2129) were already listed. Interestingly, 371 and 532 proteins
in the control and IAV set respectively carried a signal sequence, indicating that
unconventional protein secretion partly overlaps with the classical ER/Golgi
pathway and cells can employ different secretory pathways to secrete these
proteins depending on the cell’s condition (Table 7).
KEGG pathway analysis listed both “phagosome” and “endocytosis”
amongst the top three enriched pathways, supporting the hypothesis that EVs are
purposefully secreted and meant to be taken up by endocytosis in receiving cells.
This phenomenon could also stem from EVs retaining the membrane topology of
their originating cells; both pathways are very important in activated
macrophages and the membrane topology mirrors that  (Robbins and Morelli,
2014) (further discussed in chapter 4.2). In the control set, “proteasome” was the
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3rd highest  scored  pathway,  which  could  be  explained  by  the  fact  that  some
exosomes had originated from the endocytic route of the secreting cell (Figure
5). In the IAV set, “ribosome” was the second highest enriched KEGG pathway,
potentially due to translation inhibition occurring during viral infections (chapter
4.3).  GO enrichment analysis revealed the GO: Biological Process term “Antigen
processing and presentation” terms to be the most enriched in the control sets,
while EVs from infected cells had “translation”  as highest enrichment with
respect to the translation-related terms. The highest enriched GO: Molecular
Function term was GTPase in both datasets. The GO: Cellular Component noted
the highest enrichment of the extracellular vesicular exosome term, supporting
the results from experimental EV isolation.
4.1.1 EVs released from IAV infected cells contain pro-inflammatory cytokines,
FABP and COMMD proteins
The EVs isolated from IAV infected cells contained several interesting proteins,
some of which had not been previously reported to be EV-associated. Firstly,
several antiviral and pro-inflammatory cytokines were identified, including type
I IFNs IFN-?1, IFN-?14, and IFN-?; as well as pro-inflammatory cytokines IL-
6,  IL-18,  and  TNF (Study I,  table  1A).  IFNs carry  a  signal  peptide  and  hence
were thought to be secreted through the ER/Golgi pathway. Interestingly, type I
IFNs and IL-18 released upon IAV infection have been shown to synergistically
enhance IFN-? gene expression in human T cells, their co-release in EVs could
therefore prime the receiving cells and activate the adaptive immune system
(Sareneva et al., 1998). TNF, IL-6, and IL-18 had been identified in EVs before,
but their secretion could influence the pathogenesis of IAV infections and
promote pneumonia. The mechanism how these cytokines effect the target cells
upon internalisation is not yet understood, as most cytokine receptors are located
on the cell membrane.
Another interesting group were fatty-acid binding proteins (FABPs); these are
small lipid chaperones involved in lipid transport and signalling. FABP3,
FABP4, and FABP5 were exclusively identified in EVs from IAV infected cells
(Study  I,  figure  4A);  the  elevated  FABP3  and  FABP5  secretion  after  IAV
infection of human macrophages was subsequently confirmed by western
blotting  of  both  whole  secretomes  and  isolated  EVs  (Study  I,  figure  4B).
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Intracellular lipid transporter FABP5 is highly expressed in macrophages and has
been implicated in IAV infections before, as FABP5-deficient mice develop more
persistent and more severe lung inflammation after IAV infection despite a lower
virus burden, even though they were able to clear the virus faster than wild-type
mice (Gally et al., 2013). FABP5-deficiency in murine bone-marrow-derived
macrophages was reported to promote the polarization of anti-inflammatory M2
macrophages (Moore et al., 2015). These results support the suggestion that
FABP5 has a regulatory role in inflammation, and that the unconventional
secretion of FABPs could be protective against excessive oxidative damage and
therefore combatting excessive lung inflammation.
The third group of novel EV-associated proteins included seven human
copper metabolism Murr-1 domain (COMMD) proteins identified exclusively
from EVs of IAV infected cells (Study I, table 1B).
COMMD proteins are a family of 10 ubiquitously expressed proteins with
important functions in regulating translation by inhibiting NF-?B; this property
is achieved by binding NF-?B complex subunits and certain promoters of its
target genes (Bartuzi et al., 2013). While activation of NF-?B is important in the
initiation of inflammation, its downregulation is equally important to prevent
chronic inflammation and subsequent tissue damage. The identification of
COMMD  proteins  in  EVs  might  point  to  a  role  for  EVs  in  regulating  gene
expression in receiving cells. Interestingly, COMMD proteins have been
postulated to facilitate endosomal cargo sorting and thus influence the EV protein
composition (Li et al., 2015). The present result indicating EV-mediated release
of COMMD proteins suggests a novel role for these proteins in antiviral defence.
4.1.2 Involvement of Rab GTPases in EV secretion
GO: Molecular Function terms in both conditions are similar, they are all GTP
related. The Rab family is composed of more than 60 GTPases and Rab GTPases
have been demonstrated to be essential regulators of intracellular vesicle
transport between different compartments as well as being involved in the
excretion of vesicles (Colombo et al., 2014). In unpublished results, Rab GTPases
such as Rac1 were found to be induced by viral infection (Figure 9, panel A), and
pharmacological inhibition of Rac1 led to attenuated viral proteins inside of the
69
cell (Figure 9, panel B), without providing conclusive results to explain whether
this latter property is due to restricted IAV uptake or inhibited replication.
Figure 9: GTPase Rac1 plays a role in host response to IAV infection. Panel
A: Lysates of human macrophages after 9 hours’ mock- or IAV infection. IAV
infected macrophages displayed induced Rac1 production. Panel B: Lysates of
human macrophages 9 hours’ post-infection which were either untreated or
treated with Rac1 inhibitor EHT1864. Inhibition of Rac1 attenuates viral proteins
NP and NS1. Data from Lorey et al., unpublished results.
4.1.3 Involvement of autophagy pathways in unconventional protein secretion
Several viral proteins were identified from the EV dataset, including HA, NA,
NP, M1, M2, nuclear export protein, RNA-directed RNA polymerase catalytic
subunit,  PA,  PB2,  and  NS1.  NS1  is  a  protein  which  inhibits  the  IFN  type  I
response, a mechanism allowing IAV to circumvent the innate immune response.
This cannot be attributed to viral budding from the cells since IAV infections of
macrophages are usually regarded to be non-infection spreading i.e. the virus is
able to infect the cells and replicate, but virus budding is inhibited. Very few IAV
strains are able to infect macrophages productively, e.g. the Udorn/72 has not
been shown to be able to accomplish this feat (Marvin et al., 2017).
In a kinetic study, NS1 was identified in lysates of infected macrophages in a
time frame from 6 hours to 18 hours post-infection, but in EV enriched
supernatants only after 9 and 18 hours (Figure 10), suggesting that the NS1 was
being secreted from the cell and did not originate from virions which did not enter
the cells.
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Figure 10: Viral NS1 protein is unconventionally secreted from IAV infected
human macrophages. Macrophages were untreated or IAV infected for the
indicated times. Supernatants and lysates were collected and viral NS1 was
visualised by western blotting. NS1 secretion started 9 hours’ post infection, NS1
production in the cells could be detected at  6 hours’ post infection. Data from
Lorey et al., unpublished results.
Another possible explanation is that IAV uses host cell secretory pathways to
pack NS1 into vesicles, hence inhibiting the type I IFN response in cells which
take up these vesicles.
Several RNA viruses such as HIV, Hepatitis C Virus (HCV), human T-cell
lymphotropic virus (HTLV), as well as Dengue Virus (DENV) are known to alter
the exosome content such that the exosomes released from infected cells harbour
and deliver regulatory factors including viral RNA and proteins, viral and cellular
miRNA, and other factors to neighbouring cells, helping to establish productive
infections and modulating cellular responses (Chahar et al., 2015).
Viruses are able to highjack host cell secretory pathways to promote viral
budding. One of these pathways is proposed to be secretory autophagy.
Traditionally, autophagy has been thought to orchestrate the degradation and
recycling of cellular components. Targeted molecules in the cytoplasm are
isolated within a double-membraned vesicle called the autophagosome which
then fuses with a lysosome, the contents are degraded and recycled. However,
autophagy has also been shown to undertake biologically distinct, non-
degradative, roles; one of these functions is a process called secretory autophagy
(Ponpuak et al., 2015). Secretory autophagy facilitates unconventional secretion
of the cytosolic cargo, such as the secretion of leaderless proteins and even the
excretion of particulate substrates.
Golgi-associated plant pathogenesis-related protein 1 (GAPR-1), a negative
regulator of autophagy, was identified in both MS datasets alongside other
autophagy related proteins (Study I, Figure 5). In an attempt to elucidate whether
71
secretory autophagy was playing a role in the unconventional secretion from IAV
infected macrophages, silencing experiments were performed. GAPR-1 silencing
led  to  an  attenuation  of  secreted  viral  NS1  as  well  as  an  attenuation  of
unconventional protein secretion in general (Study I, figure 5), suggesting a role
for secretory autophagy in unconventional protein secretion as a host cell
response to IAV infection, as well as a potential route through which the virus
could modulate the host cell immune response in neighbouring cells.
4.1.2 Analysis of the macrophage secretome upon intracellular LPS
recognition
Study II examined the effect of non-canonical caspase-4/5 activation on the
global and unconventional protein secretion pathways in human macrophages. It
is known that caspase-4/5 inflammasome activation leads to pyroptosis, the
inflammatory cell death due to the formation of pores in the cell membrane by
truncated gasdermin D. Necrotic and pyroptotic cell death results in the release
of lactate dehydrogenase (LDH) into the growth media (Rayamajhi et al., 2013).
The caspase-4/5 inflammasome also activates the NLRP3 inflammasome,
resulting in the proteolytic activation and release of the pro-inflammatory
cytokine IL-18. Therefore, human macrophages were LPS- or mock-transfected
in a kinetic study for 1.5, 3, 4.5, and 6 hours and the conditioned media was
collected to test for LDH and IL-18 release. Both molecules were detected at 3
hours’ post transfection and their release increased in a time dependent manner
(Study II, Figure 1). Since inflammasome activation triggers EV-mediated
protein secretion, the conditioned media were further  concentrated, separated by
SDS-PAGE and silver stained (Study II, supplemental figure 1), which revealed
increased unconventional protein secretion after LPS transfection as early as 1.5
hours post-transfection, further increasing in a time dependent manner. The
increased EV secretion was validated by visualising known EV markers ITGAX,
Annexin-1, Alix, and Galectn-3 by western blot.
To confirm that this fast cell death was indeed dependent on activation of the
non-canonical inflammasome, the macrophages were pre-treated with a caspase-
4 inhibitor or left untreated before LPS transfection, conditioned media were
collected and LDH assay and IL-18 detection by Luminex were repeated,
showing complete suppression of LDH and IL-18 release after caspase-4
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inhibition (Study II, figures 2A and 2B). The EV-mediated protein secretion was
also strongly attenuated in LPS transfected cells pre-treated with caspase-4
inhibitor (Study II, figures 2C and 2D).
To obtain a more comprehensive picture of the global and EV mediated
secretion patterns upon non-canonical inflammasome activation, both EV
enriched and the flow through containing the rest-secretome fractions from
control and LPS transfected cells after 1.5 hours were analysed with quantitative
proteomics. This time point for the collection of conditioned media is somewhat
early; it was selected to avoid interference from intracellular materials being
released after pyroptotic cell death, which started as early as 3 hours post
transfection (Study II, figure 1).
Label-free quantitation in the GeLC-MS/MS workflow led to the
identification of 408 unique proteins in the EV enriched fractions and 583 from
the rest-secretome, 640 proteins were identified in both fractions. This large
overlap of proteins indicates that proteins can be secreted with distinct, yet
overlapping pathways. Proteins which were 2-fold or more upregulated in the
LPS-transfected fractions in at least 2 out of 3 independent experiments
consisting of several donors each were considered as having their secretion
increased from LPS transfected cells.
Table 8: Bioinformatic overview of study II
EV RS
Total IDs 1048 1223
Upregulated
IDs
48 36
Top 3 KEGG pathways
Proteasome Phagosome
Carbon metabolism Ribosome
Phagosome Endocytosis
Top 3 GO: Biological Process terms
Gene expression Cellular amino acid metabolic
process
Antigen processing and
presentation of peptide antigen
Carbohydrate catabolic process
Antigen processing and
presentation of exogenous antigen
Protein folding
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EV RS
Top 3 GO: Molecular Function terms
Structural constituent of ribosome Cofactor binding
Unfolded protein binding Isomerase activity
Threonine-type endopeptidase
activity
Coenzyme binding
Top 3 GO: Cellular Component terms
Extracellular vesicular exosome Extracellular vesicular
exosome
Cytosol Cytosol
Focal adhesion Focal adhesion
Top 3 IPA canonical pathways
EIF2 Signaling Protein Ubiquitination
Pathway
Protein Ubiquitination Pathway Remodeling of Epithelial
Adherens Junctions
Phagosome maturation Glycolysis I
The proteins which were upregulated upon LPS transfection were submitted
to enrichment analyses (Table 8).  KEGG pathway analyses of the EV fraction
listed “ribosome” as the highest scored term, as well as “TNF signalling” and
“Epstein-Barr virus (EBV) infection”. The EBV infection term included 4 genes
encoding for the following proteins: Intercellular adhesion molecule 1, a ligand
for the leukocyte adhesion protein LFA-1 which is essential for leukocyte trans-
endothelial migration, but acts also as a viral receptor and is inducible by TNF as
well as several other cytokines; Prothymosin-? , a DAMP and TLR4 ligand; 26S
proteasome non-ATPase regulatory subunit 1; and 14-3-3 protein theta, an
adapter protein implicated in the regulation of a large spectrum of both general
and specialized signalling pathways. One explanation for the upregulation of
proteins described by this term could be ER stress which accompanies viral
infections as well as activating the non-canonical inflammasome.
The highest scored pathways in the KEGG analysis of the RS fraction
included “antigen processing and presentation” and “phagosome”, which
represent the main functions of macrophages. The third term was “Tuberculosis”,
a disease caused by Mycobacterium tuberculosis which invades pulmonary
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alveoli, where they replicate within endosomes of alveolar macrophages, i.e. a
process also leading to intracellular PAMP sensing in macrophages.
GO analysis of the upregulated proteins in the EV fraction also implicated
viral response pathways, the two highest scoring GO: Biological function terms
were “viral transcription” and “establishment of protein localization to ER”,
indicating increased protein sorting, potentially leading to ER stress. ER stress is
a known activator of the non-canonical inflammasome, and it has also been
linked to viral transcription. The third GO: Biological function term was
“translational termination”, a major host response mechanism to microbial
infection (further discussed in chapter 4.3). GO: Molecular function as well as
Cellular component terms pointed to the EV mediated secretion of translation
related proteins. The IPA® canonical pathway analysis echoed these results with
pathway analysis scoring “EIF2 signalling”, “Regulation of eIF4 and p70S6K
signalling”, and “mTOR Signalling” as the highest three pathways. Thus,
secretion of translation related proteins is one of the main cellular responses to
LPS transfection.
GO enrichment analysis of the RS fraction listed immune response related
terms amongst the top scored in GO: Biological Process and GO: Molecular
Function. Furthermore, GO: Cellular component scored “MHC protein complex”
highest, alongside “Extracellular vesicular exosome” and “extracellular space”;
these are not easily explained results but they might point to the secretion of
outer-membrane associated proteins and membrane proteins. This could
potentially also suggest that during the centrifugation steps which are a
component of the enrichment stage, some EVs had disintegrated and both
membrane parts and cargo were able to pass through the 100 kDa cut-off filters.
IPA® pathway analysis of the RS fraction proteins scored two immunological
pathways as highest, “Aryl Hydrocarbon Receptor Signalling” and “phagosome
maturation”, as well as “prostate cancer signalling”. The aryl hydrocarbon
receptor is a ligand-activated transcription factor involved in the regulation of
biological responses to aryl compounds, but it has also been postulated to help
epithelial barrier sites to regulate bacterial loads and control opportunistic
infections (Li et al., 2011). The prostate cancer signalling term included 2 heat-
shock proteins as well as glutathione-S-transferase P, a very interesting protein
implicated in a variety of immunological functions in response to oxidative stress
(Bartolini and Galli, 2016).
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PANTHER protein class analysis of the combined upregulated proteins from
EV and RS fractions revealed the three highest enriched protein classes are
“nucleic acid binding”, “enzyme modulator”, and “signalling molecule”.
4.2.1 TNF shedding, ectosomes upon non-canonical inflammasome activation
(II)
TNF was scored as the second highest  pathway in KEGG pathway analysis of
upregulated proteins in the EV fraction (Table 8), and TNF was scored as one of
the  highest  upstream mediators  in  the  IPA® analysis  of  that  set  (Study II,  fig.
7A).   TNF,  like  many  other  cytokines  and  growth  factors,  is  synthesized  as
membrane-bound proforms that are activated and released upon proteolytic
shedding. This shedding is called ectodomain shedding; as ectodomains are the
extracellular domains of a membrane or transmembrane proteins, often these
domains initiate contact with the surfaces of other cells, leading to signal
transduction. Ectodomain shedding is facilitated by matrix metalloproteinases
(MMPs) and membrane-anchored disintegrin metalloproteinases (ADAMs)
(Khokha et al., 2013).
The STRING protein interaction analysis revealed a small cluster around
apolipoprotein E (Study II, Fig. 6A) which included matrix metalloproteinase 14
(MMP14) and Disintegrin and metalloproteinase domain-containing protein 10
(ADAM10), which were both enriched in EVs upon LPS transfection (Study II,
table 1). MMP14 and ADAM10 are known to facilitate ectodomain shedding; the
functionally similar ADAM17 (TACE). TACE induces proteolytic processing
and shedding of M-CSF, which was highly enriched in the EV fraction in all 3
biological replicates, suggesting that there had been ADAM-dependent
ectodomain shedding of M-CSF after LPS transfection.
TNF was however not identified in either fraction, and therefore a kinetic
study was performed and the supernatants were analysed by the Luminex assay.
These revealed that from 3h post transfection, there was an elevation of TNF
secretion in a time-dependent manner. Macrophages were pre-treated with a
caspase-4 inhibitor before transfection with LPS to elucidate whether the
secretion of TNF in response to intracellular LPS was dependent on caspase
activity, with the conditioned media being analysed by the Luminex assay.
Surprisingly, pre-treatment of the cells with a caspase-4 inhibitor increased
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intracellular  LPS-induced  secretion  of  TNF  (Study  II,  supplemental  Fig.  2).
Interestingly, TACE and ADAM10 have been both identified in EVs before,
where these vesicles were shown to be taken up by peripheral blood mononuclear
cells (PBMCs), triggering a rapid release of TNF (Lee et al., 2013). It is likely
that the vesicle-mediated secretion of metalloproteases MMP14 and ADAM10
upon LPS transfection may serve a similar purpose.
4.2.2 EV-mediated secretion of endogenous TLR4 ligands is activated upon
intracellular LPS stimulation
Activation of the non-canonical inflammasome triggered EV-mediated secretion
of two TLR4 ligands, S100A8 and prothymosin-?. TLR4 is the PRR which
detects also extracellular LPS, and thus the secretion of more TLR4 ligands may
prime neighbouring cells to adopt an antibacterial state. S100A8 usually forms a
heterodimer with S100A9 called calprotectin, which has been suggested as a
biomarker for a number of inflammatory diseases such as rheumatoid arthritis
(Abildtrup et al., 2015), preeclampsia (Pergialiotis et al., 2016), and as a faecal
biomarker for gastrointestinal diseases  (Burri and Beglinger, 2014),
inflammatory bowel disease, cancers and liver cirrhosis (Alibrahim et al., 2015).
It also exerts antimicrobial activity towards bacteria and fungi by sequestering
the divalent metal  ions which are necessary for microbial  growth (Brophy and
Nolan, 2015).
Secretion of calprotectin can therefore help to combat bacterial infection, but
as it has pro-inflammatory properties, this strategy can be detrimental, as it may
promote endotoxic shock (Vogl et al., 2007).  Endotoxic shock stems from the
triggering of a severe inflammatory response due to a bloodstream infection with
gram-negative bacteria; it is attributable to an overwhelming activation of the
non-canonical inflammasome (Kayagaki et al., 2013). Secretion of pro-
inflammatory TLR ligands such as calprotectin and prothymosin-? might be part
of a feedback loop which causes inflammation to change from being protective
to destructive in sepsis.
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4.2 Unconventional protein secretion is an integral part
of the innate immune response (I, II)
Activation of macrophages by IAV infection or LPS transfection triggered robust
secretion  of  EVs  (I,  II).  This  was  confirmed  by  silver  staining  and
immunoblotting. Many immunomodulating proteins were identified from the EV
fractions examined in studies I and II, and there was a notable increase in
unconventional protein secretion upon immunological stimulation. These results
support the hypothesis that extracellular protein secretion plays a role in the
innate  immune  response  to  microbial  PAMPs.  EVs  are  more  than  simply  the
packaging around biomolecular messages between cells, EVs derived from
antigen-presenting cells (APCs) such as macrophages maintain their membrane
topology  including  the  extracellular  domain  of  MHC  class  I  and  class  II
molecules and therefore can directly stimulate CD8+ and CD4+ T cells,
respectively (Robbins and Morelli, 2014).
The proteomics analysis conducted in studies I and II revealed that EVs from
control and infected or LPS-transfected macrophages contained many proteins
involved in antigen presentation, and GO term and KEGG pathway analysis
scored antigen presentation pathways as amongst the highest in all EV fractions.
Moreover, adhesion molecules and integrins were highly enriched in EVs
according to the PANTHER protein class analysis (Table 9), suggesting that EVs
can undergo endocytosis and enter into receiving cells.
Table 9: Cell adhesion molecules identified in EVs in studies I and II.
Study I Study II
Protein Name CTRL IAV EV
Cadherin-22 x
Calsyntenin-1 x x
Calsyntenin-3 x
Catenin alpha-1 x
C-C chemokine receptor-like 2 x x
CD151 antigen x x
CD166 antigen x x x
CD48 antigen x x
CD63 antigen x x
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Study I Study II
Protein Name CTRL IAV EV
CD81 antigen x x x
CD82 antigen x x x
CD9 antigen x x x
Ceruloplasmin x
Complement C1q subcomponent subunit A x x
C-type lectin domain family 4 member A x
Desmocollin-1 x x x
Desmoglein-1 x x x
Down syndrome cell adhesion molecule x
Galectin-1 x x x
Galectin-10
Galectin-3 x x x
Galectin-7 x x x
Galectin-8 x x
Galectin-9 x x x
Galectin-9B x x
Hepatitis A virus cellular receptor 2 x x
High affinity immunoglobulin gamma Fc receptor I x
Immunoglobulin superfamily member 10
Integrin beta-1 x x x
Integrin beta-2 x x x
Integrin beta-3 x x x
Integrin beta-5 x x
Intercellular adhesion molecule 1 x x x
Intercellular adhesion molecule 3 x x
Junction plakoglobin x x x
Junctional adhesion molecule-like x x
JUP x
Lactadherin x x
Leukocyte antigen CD37 x x
Leukocyte surface antigen CD47 x x x
Leukocyte surface antigen CD53 x
Low affinity immunoglobulin gamma Fc region receptor II-a x
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Study I Study II
Protein Name CTRL IAV EV
Low affinity immunoglobulin gamma Fc region receptor II-b x
Low affinity immunoglobulin gamma Fc region receptor III-A x
Melanoma-associated antigen 2 x
Myeloid cell surface antigen CD33 x x
Myosin light chain kinase, smooth muscle
Neuropilin-1 x x x
Neuropilin-2 x x x
Platelet endothelial cell adhesion molecule x x
Protein lin-7 homolog C x x
Putative high affinity immunoglobulin gamma Fc receptor IC x
Roundabout homolog 1
Sialic acid-binding Ig-like lectin 7 x x x
Sialic acid-binding Ig-like lectin 9 x x
SLAM family member 5 x x x
SLAM family member 7 x
SLAM family member 8 x x
SPARC x x x
Syndecan-2 x
Talin-1 x x x
Tetraspanin-14 x x
Tetraspanin-3 x
Tetraspanin-4 x x
Transforming growth factor-beta-induced protein ig-h3 x x x
Transmembrane glycoprotein NMB x x x
It has been demonstrated that EVs with MHC class molecules presenting
antigens on their surfaces which are taken up  by another APC can transfer this
information, and the receiving APC is able to present these antigens on its surface
(Montecalvo et al., 2008). Another route of antigen transfer is via EVs originating
from MVBs fused with early endosomes; these EVs can directly transfer antigens
from the endocytic route of a phagocyte via EV release and subsequent uptake
into another antigen-presenting cell and thus amplify the immune response
(Robbins and Morelli, 2014).
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New studies have claimed that EVs transfer not only antigens to APCs but
also danger signals that may promote the differentiation of the acceptor cells into
immunogenic APCs. Macrophages that have been infected with Mycobacterium
tuberculosis, Mycobacterium bovis BCG, Salmonella typhimurium, or
Toxoplasma gondii release EVs carrying microbial antigens and PAMPs. These
EVs stimulate a proinflammatory response in a TLR– and myeloid differentiation
factor 88 (Myd88)–dependent manner when added into the culture media of
uninfected macrophages (Bhatnagar et al., 2007). In essence, these EVs act like
intrinsic adjuvants, which could explain why EVs are more efficient than soluble
peptides at transferring antigens between APCs (Testa et al., 2010, Thery et al.,
2009). In addition, virus-infected and ?-glucan stimulated cells secrete DAMPs
(reviewed in(Nyman et al., 2017)).
Inflammasome activation, more specifically caspase-1 activation, has been
linked to EV-mediated protein secretion for almost a decade (Keller et al., 2008),
and many NLRP3 inflammasome activators are known to induce robust
unconventional vesicle-mediated protein secretion in human macrophages
(Cypryk et al., 2014, Ohman et al., 2014, Valimaki et al., 2016, Valimaki et al.,
2013)  The essential proteins for NLRP3 activation are the lysosomal proteases
cathepsins, which were identified in EVs after NLRP3 inflammasome activation
(Valimaki et al., 2013, Ohman et al., 2014). Furthermore, EVs from macrophages
stimulated with the NLRP3 activator, nigericin, contained several TLRs, as well
as  components  of  the  NF-?B and NLRP3 inflammasome signalling  pathways,
and have been shown to directly activate the NF-?B signalling pathway,
amplifying the inflammatory signalling in neighbouring cells in an exosome-
dependent manner (Zhang et al., 2016). Therefore, it is likely that the
unconventional secretion of NLRP3 inflammasome activators can activate the
NLRP3 inflammasome in recipient cells and enhance inflammatory responses in
recipient cells.
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4.3 Translation inhibition is an innate immune response
mechanism against microbial infections (I, II)
In  the  secretomics  studies  of  both  IAV  infected  macrophages  (I)  as  well  as
macrophages with intracellular LPS (II) the EV isolates and EV enriched
fractions contained a large amount of ribosomal and translation related proteins
(Table 10).
Table 10: Ribosomal proteins identified in EVs from stimulated
macrophages in studies I and II. In the LPS experiment, “x” marks proteins
identified in the dataset which were minimally 2-fold enriched in at least 2 out of
3 experiments without an opposite value in the third experiment, “o” marks
identified in the dataset.
Protein names IAV LPS Protein names IAV LPS
40S ribosomal protein S2 x o 60S ribosomal protein L3 x o
40S ribosomal protein S3 x x 60S ribosomal protein L4  x o
40S ribosomal protein S3a x x 60S ribosomal protein L5 x o
40S ribosomal protein S4,
X isoform x o 60S ribosomal protein L6 x
40S ribosomal protein S4,
Y isoform 1 x 60S ribosomal protein L7a
40S ribosomal protein S4,
Y isoform 2 60S ribosomal protein L7 x o
40S ribosomal protein S5 x o 60S ribosomal protein L8 x x
40S ribosomal protein S6 x x 60S ribosomal protein L9 x
40S ribosomal protein S7 x x 60S ribosomal proteinL10a x o
40S ribosomal protein S8 x x 60S ribosomal protein L10 x
40S ribosomal protein S9 x 60S ribosomal protein L11 x o
40S ribosomal protein S10 x o 60S ribosomal protein L12 x o
40S ribosomal protein S11 x x 60S ribosomal proteinL13a x o
40S ribosomal protein S12 x o 60S ribosomal protein L13 x o
40S ribosomal protein S13 x x 60S ribosomal protein L14 x x
40S ribosomal protein S14 x x 60S ribosomal protein L15 x
40S ribosomal protein S15  x 60S ribosomal protein L17 x
82
Protein names IAV LPS Protein names IAV LPS
40S ribosomal protein S15a x x 60S ribosomal proteinL18a x
40S ribosomal protein S16 x o 60S ribosomal protein L18 x o
40S ribosomal protein S17 x o 60S ribosomal protein L19 x
40S ribosomal protein S18 x o 60S ribosomal protein L21 x
40S ribosomal protein S19 x x 60S ribosomal protein L22 x o
40S ribosomal protein S20 x o 60S ribosomal proteinL23a x x
40S ribosomal protein S21 x o 60S ribosomal protein L23 x o
40S ribosomal protein S23 x o 60S ribosomal protein L24 x
40S ribosomal protein S24 x 60S ribosomal protein L26 x
40S ribosomal protein S25 x x 60S ribosomal proteinL27a x
40S ribosomal protein S26 x 60S ribosomal protein L27 x
40S ribosomal protein S27 x 60S ribosomal protein L28 x
40S ribosomal protein S28 x 60S ribosomal protein L29 x
40S ribosomal protein S29 60S ribosomal protein L30 x x
40S ribosomal protein S30 x 60S ribosomal protein L31 x
40S ribosomal protein SA x o 60S ribosomal protein L32 x
60S ribosomal protein L34 x
60S ribosomal protein
L35a x o
60S ribosomal protein L35 x
60S ribosomal protein
L36a x
60S ribosomal protein L36 x
60S ribosomal protein
L37a x
60S ribosomal protein L37
60S ribosomal protein L38 x
60S ribosomal protein L39
Ubiquitin-60S ribosomal
protein L40 o
60S ribosomal protein L41
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Protein names IAV LPS Protein names IAV LPS
60S acidic ribosomal
protein P0 x
60S acidic ribosomal
protein P1 x
60S acidic ribosomal
protein P2 x o
The ribosome is the cellular protein synthesis machinery, eukaryotic
ribosomes have two subunits, designated the small subunit (40S) and the large
subunit (60S). Both subunits contain ribosomal proteins arranged on a scaffold
composed of ribosomal RNA (rRNA). In order to initiate translation of most
eukaryotic messenger RNAs (mRNAs), an initiation complex containing the 40S
ribosome, GTP and the initiator transfer RNA (tRNA) called the 43S complex is
recruited by eukaryotic translation initiation factors (eIFs). The initiation of
translation can be impaired by phosphorylation of the regulatory subunit of eIF2
by a family of four kinases that  respond to starvation or various other cellular
stresses (Table 11)  (Donnelly et al., 2013). In Figure 6 of study II, translation
inhibition by phosphorylation of eIF2? upon non-canonical inflammasome
activation was confirmed by western blot, which is evidence for a directed
inhibition of translation in gram-negative bacterial infections.
Table 11: elF2? phosphorylating stress kinases
Name Induced by
Protein kinase R (PKR) Viral infection, ER stress, oxidative stress,cytokine signalling,  growth factors
General control nonderepressible 2
(GCN2)
Amino acid deprivation, viral infection, UV-
irradiation
PRK-like endoplasmic reticulum
kinase (PERK) ER stress, oxidative stress
Heme-regulated eIF2? kinase (HRI) Heme depletion, binding of NO to heme,oxidative stress, proteasome inhibition
Interestingly many viruses themselves use this strategy and impair the
ribosome recruitment to host cell mRNAs in order to abolish host antiviral
responses in favour of viral protein synthesis, which in these instances proceeds
via an alternative initiation strategy (Walsh et al., 2013).
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Bacteria on the other hand possess their own protein synthesis tools, and thus
it is less obvious that translation inhibition would benefit the microorganism in
its attempts to infect the host cell. However, it has been reported that inhibition
of translation is involved also in the host response to bacterial pathogens, e.g.
infection of Drosophila melanogaster with gram-negative bacteria Pseudomonas
entomophila induced global suppression of translation in the fly gut (Chakrabarti
et al.). This translation inhibition was achieved by phosphorylation of eIF2? by
GCN2.
Chronic pathogen infection can induce persistent, unresolved ER stress.
PERK, which is activated by ER stress and phosphorylates eIF2?, suppresses
global translation but promotes the translation of a subset of cellular mRNAs with
upstream open reading frames including some encoding for transcription factors
triggering apoptosis if synthesised continuously. Certain bacterial components
such as  LPS, cytolysins, and intracellular-acting toxins all induce ER stress
(Lemaitre and Girardin, 2013). During ER stress, macrophage TLR4 signalling
stimulates eIF2B GEF activity, which enables the continued synthesis of essential
proteins without activating these transcription factors (Woo et al., 2012).
The translation inhibition by phosphorylation of eIF2? and the massive
secretion of ribosomal proteins upon non-canonical inflammasome activation in
study II indicates that these are more general tools of the innate immune response
than previously recognized. Further studies will be needed to elucidate whether
bacterial PAMPs themselves cause translation inhibition, or whether the DAMPs
originating from damaged cells and ER stress are the factors inducing this
phenomenon.
85
V Conclusions and future perspectives
Proteomics analyses have proven to be a valuable tool for gaining a deeper
understanding of immunology (reviewed in (Nyman et al., 2017)). Secretomics
plays a major role in this respect as it helps to clarify intercellular communication.
Recent studies have identified virulence factors, vaccine candidates, and
biomarkers, and these have exerted a major impact on immunology (reviewed in
(Nyman et al., 2017)). In studies I and II, secretomics analysis of cells infected
with IAV or transfected with LPS made it possible to gain a deeper understanding
of the responses of the host cell, in this case - human macrophages. These cells
are key players in the innate immune response since they communicate with other
immune cells through both conventional ER-Golgi and unconventional, EV-
mediated protein secretion.
Our results are in line with the proposed major role of EVs as intercellular
messengers in health and disease, highlighting need for future EV secretome
studies to clarify and potentially target therapeutically important intercellular
messages. These present results deepened our understanding of the host cell’s
response to microbial infections; translation inhibition was shown to be not only
a  response  to  viral  infection,  but  was  found  also  to  play  a  role  in  bacterial
infections. The results warrant further studies, especially kinetic studies to place
translation inhibition as an innate immune response into a time-resolved map of
other cellular responses. Importantly, the effect of enriched EVs on untreated
control cells has to be studied to truly understand the effect of EVs as intercellular
communication tools.
IAVs infect many millions of people worldwide causing as many as half a
million fatalities every year. Study I is the first comprehensive proteomic and
bioinformatics analysis of the EVs secreted during IAV infection of human
macrophages, and led to the identification of several novel EV-associated
proteins including antiviral cytokines, COMMD proteins, FABPs, and
autophagy-related proteins. The EVs also carried signalling molecules such as
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kinases and transcription factors that can potentially modulate the cellular
response in neighbouring uninfected cells. This EV secretion during viral
infection is potentially hijacked by the virus to spread a known antagonist of the
type I IFN response to uninfected cells, neatly packaged in EVs, reminiscent of
a Trojan horse. Recent advances have made it possible to overcome the technical
limitations of microscopy, newer super resolution microscopy methods such as
stochastic optical reconstruction microscopy (STORM) imaging are able to
provide a nanoscale view of virus replication and cell biology (Grove, 2014). In
future co-localisation studies, this method could be used to validate viral NS1 in
EVs by labelling viral NS1 as well as virion markers HA or NA, in addition to
recognized EV markers such as Alix, Annexin, or ITGAX. If it can be confirmed
beyond  a  doubt  that  NS1  is  packed  into  host  cell  EVs,  this  Trojan  horse
mechanism could be a potentially important therapeutical target to prevent viral
infections. One starting point could be Rab GTPase Rac1, which is believed to
have a role in facilitating unconventional protein secretion and which also
influences viral replication inside the host cell. Further functional studies will be
needed to unravel the diverse roles of Rac1 in viral infection. Furthermore, the
roles of FABPs and COMMD proteins in viral infection and EV secretion should
be clarified.
The non-canonical inflammasome may be a recent discovery but it is having
a major impact on inflammation research, whether they are acute, as in endotoxic
shock (Hagar et  al.,  2013),  or chronic,  as in inflammatory diseases.  Study II  is
the first comprehensive characterisation of the secretome after caspase-4/5
activation, showing that the secreted proteins have critical roles in the host
response mounted against a severe gram-negative bacterial infection. The
findings of study II that secretion of TLR4 ligands is activated by the caspase-
4/5 inflammasome could be part of a positive feedback-loop in severe
inflammation which can become life-threatening in endotoxic shock.
Interestingly, the release of the pro-inflammatory TNF was independent from
caspase-4/5 activation, even though it was found that mechanisms to release both
TNF and anti-inflammatory M-CST were increasingly secreted upon intracellular
LPS recognition. Therefore, more studies will be required to elucidate the role of
the secreted proteins, and to understand their secretion mechanisms; it is evident
that mediation of the inflammatory response is the key to successful treatment of
both chronic and acute inflammation. Since most research on the non-canonical
inflammasome has been conducted in mice or mouse cells, in the future, human
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cells could be utilised to provide a more comprehensive view of disease
pathogenesis in humans. Intracellular signalling after non-canonical
inflammasome activation should be studied to understand better EV biogenesis
in acute inflammation states as well as how it initiates pyroptosis. This could be
achieved by exploiting proteomics, focusing on phosphorylation, which also
exerts a huge impact in mediating host responses (reviewed in (Nyman et al.,
2017)). These results could prove crucial in treating various severe diseases,
some of which lack effective therapies today.
In conclusion, the results support the view that secretome analysis is a cutting
edge tool with which to dissect cellular responses, and hopefully the studies
described in this doctoral thesis may represent the foundation of several future
projects which will lead to new medical treatments for viral infections and
inflammatory diseases.
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